<SEC-DOCUMENT>0001193125-24-040003.txt : 20240220
<SEC-HEADER>0001193125-24-040003.hdr.sgml : 20240220
<ACCEPTANCE-DATETIME>20240220161908
ACCESSION NUMBER:		0001193125-24-040003
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		20
CONFORMED PERIOD OF REPORT:	20240220
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20240220
DATE AS OF CHANGE:		20240220

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			EASTMAN CHEMICAL CO
		CENTRAL INDEX KEY:			0000915389
		STANDARD INDUSTRIAL CLASSIFICATION:	PLASTICS, MATERIALS, SYNTH RESINS & NONVULCAN ELASTOMERS [2821]
		ORGANIZATION NAME:           	08 Industrial Applications and Services
		IRS NUMBER:				621539359
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-12626
		FILM NUMBER:		24653589

	BUSINESS ADDRESS:	
		STREET 1:		PO BOX 511
		STREET 2:		200 SOUTH WILCOX DRIVE
		CITY:			KINGSPORT
		STATE:			TN
		ZIP:			37660
		BUSINESS PHONE:		4232292000

	MAIL ADDRESS:	
		STREET 1:		P O BOX 511 B-54D
		CITY:			KINGSPORT
		STATE:			TN
		ZIP:			37662
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d681849d8k.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:us-types="http://fasb.org/us-types/2023" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:emn="http://www.eastman.com/20240220" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns="http://www.w3.org/1999/xhtml">
<head>
<title>8-K</title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
   <body><div style="display:none"> <ix:header> <ix:hidden> <ix:nonNumeric id="Hidden_dei_EntityRegistrantName" name="dei:EntityRegistrantName" contextRef="duration_2024-02-20_to_2024-02-20">EASTMAN CHEMICAL CO</ix:nonNumeric> <ix:nonNumeric name="dei:AmendmentFlag" contextRef="duration_2024-02-20_to_2024-02-20" id="ixv-314">false</ix:nonNumeric> <ix:nonNumeric id="Hidden_dei_EntityCentralIndexKey" name="dei:EntityCentralIndexKey" contextRef="duration_2024-02-20_to_2024-02-20">0000915389</ix:nonNumeric> </ix:hidden> <ix:references> <link:schemaRef xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xlink:type="simple" xlink:href="emn-20240220.xsd" xlink:arcrole="http://www.xbrl.org/2003/linkbase"/> </ix:references> <ix:resources> <xbrli:context id="duration_2024-02-20_to_2024-02-20"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0000915389</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:startDate>2024-02-20</xbrli:startDate> <xbrli:endDate>2024-02-20</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="duration_2024-02-20_to_2024-02-20_us-gaap-StatementClassOfStockAxis_us-gaap-CommonStockMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0000915389</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2024-02-20</xbrli:startDate> <xbrli:endDate>2024-02-20</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="duration_2024-02-20_to_2024-02-20_us-gaap-StatementClassOfStockAxis_us-gaap-DeferrableNotesMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0000915389</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:DeferrableNotesMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2024-02-20</xbrli:startDate> <xbrli:endDate>2024-02-20</xbrli:endDate> </xbrli:period> </xbrli:context> </ix:resources> </ix:header> </div> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"> <p style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p> <p style="margin-top:4pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">UNITED STATES</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">SECURITIES AND EXCHANGE COMMISSION</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">WASHINGTON, DC 20549</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:10pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">FORM <span style="white-space:nowrap"><ix:nonNumeric name="dei:DocumentType" contextRef="duration_2024-02-20_to_2024-02-20" id="ixv-341">8-K</ix:nonNumeric></span></p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:10pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">CURRENT REPORT</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Pursuant to Section&#160;13 or 15 (d)</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">of The Securities Exchange Act of 1934</p> <p style="margin-top:10pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Date of report (Date of earliest event reported):</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:DocumentPeriodEndDate" contextRef="duration_2024-02-20_to_2024-02-20" format="ixt:datemonthdayyearen" id="ixv-342">February&#160;20, 2024</ix:nonNumeric></p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:10pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman;font-weight:bold;text-align:center"> <span style=" -sec-ix-hidden:Hidden_dei_EntityRegistrantName">EASTMAN CHEMICAL COMPANY</span> </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Exact Name of Registrant as Specified in Its Charter)</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:34%"/>
<td style="vertical-align:bottom"/>
<td style="width:32%"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:32%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityIncorporationStateCountryCode" contextRef="duration_2024-02-20_to_2024-02-20" format="ixt-sec:stateprovnameen" id="ixv-343">Delaware</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><span style="white-space:nowrap"><ix:nonNumeric name="dei:EntityFileNumber" contextRef="duration_2024-02-20_to_2024-02-20" id="ixv-344">1-12626</ix:nonNumeric></span></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><span style="white-space:nowrap"><ix:nonNumeric name="dei:EntityTaxIdentificationNumber" contextRef="duration_2024-02-20_to_2024-02-20" id="ixv-345">62-1539359</ix:nonNumeric></span></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(State or Other Jurisdiction</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">of Incorporation)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold">(Commission<br/>File Number)</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(IRS Employer</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Identification No.)</p></td></tr></table> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityAddressAddressLine1" contextRef="duration_2024-02-20_to_2024-02-20" id="ixv-346">200 South Wilcox Drive</ix:nonNumeric></p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityAddressCityOrTown" contextRef="duration_2024-02-20_to_2024-02-20" id="ixv-347">Kingsport</ix:nonNumeric> <ix:nonNumeric name="dei:EntityAddressStateOrProvince" contextRef="duration_2024-02-20_to_2024-02-20" format="ixt-sec:stateprovnameen" id="ixv-348">Tennessee</ix:nonNumeric> <ix:nonNumeric name="dei:EntityAddressPostalZipCode" contextRef="duration_2024-02-20_to_2024-02-20" id="ixv-349">37660</ix:nonNumeric></p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Address of Principal Executive Offices) (Zip Code)</p> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:CityAreaCode" contextRef="duration_2024-02-20_to_2024-02-20" id="ixv-350">(423)</ix:nonNumeric> <span style="white-space:nowrap"><ix:nonNumeric name="dei:LocalPhoneNumber" contextRef="duration_2024-02-20_to_2024-02-20" id="ixv-351">229-2000</ix:nonNumeric></span></p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Registrant&#8217;s Telephone Number, Including Area Code)</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Check the appropriate box below if the Form <span style="white-space:nowrap">8-K</span> filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:WrittenCommunications" contextRef="duration_2024-02-20_to_2024-02-20" format="ixt-sec:boolballotbox" id="ixv-352">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:SolicitingMaterial" contextRef="duration_2024-02-20_to_2024-02-20" format="ixt-sec:boolballotbox" id="ixv-353">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Soliciting material pursuant to Rule <span style="white-space:nowrap">14a-12</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.14a-12)</span></p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:PreCommencementTenderOffer" contextRef="duration_2024-02-20_to_2024-02-20" format="ixt-sec:boolballotbox" id="ixv-354">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="white-space:nowrap">Pre-commencement</span> communications pursuant to Rule <span style="white-space:nowrap">14d-2(b)</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.14d-2(b))</span></p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:PreCommencementIssuerTenderOffer" contextRef="duration_2024-02-20_to_2024-02-20" format="ixt-sec:boolballotbox" id="ixv-355">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="white-space:nowrap">Pre-commencement</span> communications pursuant to Rule <span style="white-space:nowrap">13e-4(c)</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.13e-4(c))</span></p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Securities registered pursuant to Section&#160;12(b) of the Act:</p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:34%"/>
<td style="vertical-align:bottom"/>
<td style="width:32%"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:32%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Title of each class</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Trading<br/>Symbol(s)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Name of each exchange<br/>on which registered</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric name="dei:Security12bTitle" contextRef="duration_2024-02-20_to_2024-02-20_us-gaap-StatementClassOfStockAxis_us-gaap-CommonStockMember" id="ixv-356">Common Stock, par value $0.01 per share</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric name="dei:TradingSymbol" contextRef="duration_2024-02-20_to_2024-02-20_us-gaap-StatementClassOfStockAxis_us-gaap-CommonStockMember" id="ixv-357">EMN</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric name="dei:SecurityExchangeName" contextRef="duration_2024-02-20_to_2024-02-20_us-gaap-StatementClassOfStockAxis_us-gaap-CommonStockMember" format="ixt-sec:exchnameen" id="ixv-358">New York Stock Exchange</ix:nonNumeric></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:bottom"><ix:nonNumeric name="dei:Security12bTitle" contextRef="duration_2024-02-20_to_2024-02-20_us-gaap-StatementClassOfStockAxis_us-gaap-DeferrableNotesMember" id="ixv-359">1.875% Notes Due 2026</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:bottom"><ix:nonNumeric name="dei:TradingSymbol" contextRef="duration_2024-02-20_to_2024-02-20_us-gaap-StatementClassOfStockAxis_us-gaap-DeferrableNotesMember" id="ixv-360">EMN26</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:bottom"><ix:nonNumeric name="dei:SecurityExchangeName" contextRef="duration_2024-02-20_to_2024-02-20_us-gaap-StatementClassOfStockAxis_us-gaap-DeferrableNotesMember" format="ixt-sec:exchnameen" id="ixv-361">New York Stock Exchange</ix:nonNumeric></td></tr></table> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule <span style="white-space:nowrap">12b-2</span> of the Securities Exchange Act of 1934 <span style="white-space:nowrap">(&#167;240.12b-2</span> of this chapter).</p> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Emerging growth company&#8194;<ix:nonNumeric name="dei:EntityEmergingGrowthCompany" contextRef="duration_2024-02-20_to_2024-02-20" format="ixt-sec:boolballotbox" id="ixv-362">&#9744;</ix:nonNumeric></p> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section&#160;13(a) of the Exchange Act.&#8194;&#9744;</p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <p style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p></div></div>

<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#8201;1.01.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Entry into a Material Definitive Agreement. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On February&#160;20, 2024, Eastman Chemical Company (the &#8220;Company&#8221;) issued $750,000,000 aggregate principal amount of 5.625% Notes due 2034 (the &#8220;Notes&#8221;) in a public offering pursuant to a registration statement on Form <span style="white-space:nowrap">S-3</span> (File <span style="white-space:nowrap">No.&#160;333-257008)</span> and a preliminary prospectus supplement and prospectus supplement related to the offering of the Notes, each as previously filed with the SEC. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Notes were issued under an indenture, dated as of June&#160;5, 2012 (the &#8220;Indenture&#8221;), by and between the Company and Computershare Trust Company, National Association (as successor to Wells Fargo Bank, National Association), as trustee (the &#8220;Trustee&#8221;). </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Notes will mature on February&#160;20, 2034. Interest on the Notes will be paid semi-annually in arrears on February&#160;20 and August&#160;20 of each year, commencing on August&#160;20, 2024, to the persons in whose names such Notes are registered in the security register at the close of business on the February&#160;5 or August&#160;5 preceding the relevant interest payment date, except that interest payable at maturity shall be paid to the same persons to whom principal of the Notes is payable. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Prior to November&#160;20, 2033 (three months prior to the Notes maturity date (the &#8220;Par Call Date&#8221;)), the Company may redeem the Notes at its option, in whole or in part, at any time and from time to time, at a redemption price (expressed as a percentage of principal amount and rounded to three decimal places) equal to the greater of: (1)(a) the sum of the present values of the remaining scheduled payments of principal and interest thereon discounted to the redemption date (assuming the Notes matured on the Par Call Date) on a semi-annual basis (assuming a <span style="white-space:nowrap">360-day</span> year consisting of twelve <span style="white-space:nowrap">30-day</span> months) at the Treasury Rate (as defined in the Notes) plus 25 basis points less (b)&#160;interest accrued to the date of redemption, and (2) 100% of the principal amount of the Notes to be redeemed, plus, in either case, accrued and unpaid interest thereon to the redemption date. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition, on and after the Par Call Date, the Company may redeem some or all of the Notes at a redemption price equal to 100% of the principal amount of the Notes to be redeemed, plus accrued and unpaid interest, if any, to the date of redemption. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Indenture and the Notes contain covenants that, among other things, restrict the ability of the Company to incur certain secured indebtedness, enter into sale and leaseback transactions and consolidate, merge or transfer all or substantially all of its assets and the assets of its subsidiaries on a consolidated basis. These covenants are subject to a number of important exceptions and qualifications. Upon the occurrence of a change of control (as defined in the Indenture) and a contemporaneous downgrade of the Notes below an investment grade rating by both Moody&#8217;s Investors Service, Inc. and S&amp;P Global Ratings, a division of S&amp;P Global, Inc., the Company will be required to make an offer to purchase the Notes at a price equal to 101% of the principal amount of the Notes, plus any accrued and unpaid interest to, but excluding, the date of repurchase. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Notes are general unsecured obligations of the Company. The Notes rank equally in right of payment with existing and any future unsecured and unsubordinated indebtedness of the Company and rank senior in right of payment to any existing and future indebtedness of the Company that is subordinated to the Notes. The Notes are also effectively subordinated to any existing and future secured indebtedness of the Company to the extent of the assets securing such indebtedness, and are structurally subordinated to all existing and any future indebtedness and any other liabilities of its subsidiaries. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Upon the occurrence of an event of default under the Indenture, which includes payment defaults, defaults in the performance of affirmative and negative covenants and bankruptcy and insolvency-related defaults, the obligations of the Company under the Notes may be accelerated, in which case the entire principal amount of the Notes would be immediately due and payable. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Wilmer Cutler Pickering Hale and Dorr LLP, counsel to the Company, has issued an opinion to the Company, dated February&#160;20, 2024, regarding the Notes. A copy of this opinion is filed as Exhibit 5.1 hereto. </p>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The foregoing description is qualified in its entirety by reference to the full text of the Indenture, which is filed with this report as Exhibit 4.1 hereto, and the full text of the Notes, the form of which is filed with this report as Exhibit 4.2 hereto. Each of the foregoing documents is incorporated herein by reference.</p> <p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#8201;8.01.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Other Events. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The sale of the Notes was made pursuant to the terms of an Underwriting Agreement, which the Company entered into on February&#160;15, 2024 (the &#8220;Underwriting Agreement&#8221;), with BofA Securities, Inc., Citigroup Global Markets Inc., J.P. Morgan Securities LLC, Mizuho Securities USA LLC and Wells Fargo Securities, LLC, as representatives of the several underwriters listed in Schedule 1 to the Underwriting Agreement. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company expects that the net proceeds from the sale of the Notes will be approximately $742.1&#160;million, after deducting the underwriting discounts and estimated offering expenses. The Company intends to use the net proceeds from the sale of the Notes for general corporate purposes, which may include working capital, capital expenditures, the repayment of other indebtedness outstanding from time to time, and other matters in connection with the implementation of our strategic initiatives. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The foregoing description is qualified in its entirety by reference to the full text of the Underwriting Agreement, which is filed with this report as Exhibit 1.1 hereto and is incorporated herein by reference. </p> <p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#8201;9.01</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">(d) Exhibits </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(d) Exhibits </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">


<tr>

<td/>
<td/>
<td style="vertical-align:bottom"/>

<td style="vertical-align:bottom;width:5%"/>
<td style="width:92%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td colspan="2" style="vertical-align:bottom;white-space:nowrap"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman;font-weight:bold">Number</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom" align="center"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:inline-block; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Exhibit</p></td></tr>


<tr style="font-size:1pt">
<td style="height:6pt" colspan="3"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="white-space:nowrap;vertical-align:top">&#160;</td>
<td style="white-space:nowrap;vertical-align:top" align="right">1.1</td>
<td style="white-space:nowrap;vertical-align:top">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d681849dex11.htm">Underwriting Agreement, dated February&#160;15, 2024, by and among Eastman Chemical Company and BofA Securities, Inc., Citigroup Global Markets Inc., J.P. Morgan Securities LLC, Mizuho Securities USA LLC and Wells Fargo Securities, LLC, as representatives of the several underwriters listed in Schedule 1 thereto </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt" colspan="3"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="white-space:nowrap;vertical-align:top">&#160;</td>
<td style="white-space:nowrap;vertical-align:top" align="right">4.1</td>
<td style="white-space:nowrap;vertical-align:top">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="http://www.sec.gov/Archives/edgar/data/915389/000119312512259725/d362069dex41.htm">Indenture, dated June<span style="text-decoration:underline"></span>&#160;5, 2012, by and between Eastman Chemical Company and Computershare Trust Company, National Association (as successor to Wells Fargo Bank, National Association), as trustee (incorporated herein by reference to Exhibit 4.1 to the Company&#8217;s Current Report on Form<span style="text-decoration:underline"></span><span style="white-space:nowrap">&#160;8-K</span><span style="text-decoration:underline"></span>&#160;dated June<span style="text-decoration:underline"></span>&#160;5, 2012)</a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt" colspan="3"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="white-space:nowrap;vertical-align:top">&#160;</td>
<td style="white-space:nowrap;vertical-align:top" align="right">4.2</td>
<td style="white-space:nowrap;vertical-align:top">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d681849dex42.htm">Form of 5.625% Note due 2034 </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt" colspan="3"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="white-space:nowrap;vertical-align:top">&#160;</td>
<td style="white-space:nowrap;vertical-align:top" align="right">5.1</td>
<td style="white-space:nowrap;vertical-align:top">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d681849dex51.htm">Opinion of Wilmer Cutler Pickering Hale and Dorr LLP </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt" colspan="3"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="white-space:nowrap;vertical-align:top">&#160;</td>
<td style="white-space:nowrap;vertical-align:top" align="right">23.1</td>
<td style="white-space:nowrap;vertical-align:top">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d681849dex51.htm">Consent of Wilmer Cutler Pickering Hale and Dorr LLP (contained in Exhibit 5.1 above) </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt" colspan="3"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="white-space:nowrap;vertical-align:top">&#160;</td>
<td style="white-space:nowrap;vertical-align:top" align="right">104</td>
<td style="white-space:nowrap;vertical-align:top">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Cover Page Interactive Data File (embedded with the Inline XBRL document)</td></tr>
</table>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p><div>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:40%;border:0;margin-left:auto">


<tr>

<td style="width:7%"/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:92%"/></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top" colspan="3"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman;font-weight:bold">Eastman Chemical Company</p></td></tr>
<tr style="font-size:1pt">
<td style="height:12pt"/>
<td style="height:12pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">By:</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Kevin Wang</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">Kevin Wang</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">Vice President and Treasurer</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">Date: February&#160;20, 2024</td></tr>
</table></div>
</div></div>

</body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-1.1
<SEQUENCE>2
<FILENAME>d681849dex11.htm
<DESCRIPTION>EX-1.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-1.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 1.1 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B><I>Execution Version </I></B></P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>EASTMAN CHEMICAL COMPANY </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>$750,000,000 5.625% Notes due 2034<SUP STYLE="font-size:75%; vertical-align:top"> </SUP> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>Underwriting Agreement </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">February&nbsp;15, 2024 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">BofA Securities, Inc.
</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Citigroup Global Markets Inc. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">J.P. Morgan Securities LLC
</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Mizuho Securities USA LLC </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Wells Fargo Securities,
LLC&#8195; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">As Representatives of the </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">several Underwriters listed </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">in
Schedule 1 hereto </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">c/o BofA Securities, Inc. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">One Bryant
Park </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">New York, New York 10036 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">c/o Citigroup Global Markets
Inc. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">388 Greenwich Street </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">New York, New York 10013 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">c/o J.P. Morgan Securities LLC </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">383 Madison Avenue </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">New York, New York 10179 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">c/o Mizuho Securities USA LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">1271 Avenue of the Americas </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">New York, New York 10020 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">c/o Wells Fargo Securities, LLC </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">550 South Tryon Street, 5th
Floor </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Charlotte, North Carolina 28202&#8195; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Ladies and
Gentlemen: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Eastman Chemical Company, a Delaware corporation (the &#147;<B>Company</B>&#148;), proposes to issue and sell to the several
Underwriters listed in Schedule 1 hereto (the &#147;<B>Underwriters</B>&#148;), for whom you are acting as representatives (the &#147;<B>Representatives</B>&#148;), $750,000,000 aggregate principal amount of its 5.625% Notes due 2034 (the
&#147;<B>Securities</B>&#148;). The Securities will be issued pursuant to an Indenture dated as of June&nbsp;5, 2012 (the &#147;<B>Indenture</B>&#148;) between the Company and Computershare Trust Company, National Association (as successor to Wells
Fargo Bank, National Association), as trustee (the &#147;<B>Trustee</B>&#148;). </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company hereby confirms its agreement with the several Underwriters concerning the
purchase and sale of the Securities, as follows: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1. <U>Registration Statement</U>. The Company has prepared and filed with the Securities
and Exchange Commission (the &#147;<B>Commission</B>&#148;) under the Securities Act of 1933, as amended, and the rules and regulations of the Commission thereunder (collectively, the &#147;<B>Securities</B> <B>Act</B>&#148;), a registration
statement on Form <FONT STYLE="white-space:nowrap">S-3</FONT> (File <FONT STYLE="white-space:nowrap">No.&nbsp;333-257008),</FONT> including a prospectus (the &#147;<B>Base</B> <B>Prospectus</B>&#148;), relating to the Securities. The Company has
also filed, or proposes to file, with the Commission pursuant to Rule 424 under the Securities Act a prospectus supplement specifically relating to the Securities (the &#147;<B>Prospectus</B> <B>Supplement</B>&#148;). Such registration statement, as
amended at the time it became effective, including the information, if any, deemed pursuant to Rule 430A or 430B under the Securities Act to be part of the registration statement at the time of its effectiveness (&#147;<B>Rule 430
Information</B>&#148;), is referred to herein as the &#147;<B>Registration</B> <B>Statement</B>&#148;; and as used herein, the term &#147;<B>Preliminary</B> <B>Prospectus</B>&#148; means the preliminary Prospectus Supplement specifically relating to
the Securities together with the Base Prospectus, and the term &#147;<B>Prospectus</B>&#148; means the Base Prospectus as supplemented by the Prospectus Supplement specifically relating to the Securities in the form first used (or made available
upon request of purchasers pursuant to Rule 173 under the Securities Act) in connection with a confirmation of sales of the Securities. Any reference in this Agreement to the Registration Statement, any Preliminary Prospectus or the Prospectus shall
be deemed to refer to and include the documents incorporated by reference therein pursuant to Item 12 of Form <FONT STYLE="white-space:nowrap">S-3</FONT> under the Securities Act, as of the effective date of the Registration Statement or the date of
such Preliminary Prospectus or the Prospectus, as the case may be, and any reference to &#147;amend&#148;, &#147;amendment&#148; or &#147;supplement&#148; with respect to the Registration Statement, any Preliminary Prospectus or the Prospectus shall
be deemed to refer to and include any documents filed after such date under the Securities Exchange Act of 1934, as amended, and the rules and regulations of the Commission thereunder (collectively, the &#147;<B>Exchange</B> <B>Act</B>&#148;) that
are deemed to be incorporated by reference therein. Capitalized terms used but not defined herein shall have the meanings given to such terms in the Registration Statement and the Prospectus. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">At or prior to the time when sales of the Securities were first made (the &#147;<B>Time of Sale</B>&#148;), the Company had prepared the
following information (collectively, the &#147;<B>Time of Sale Information</B>&#148;): a Preliminary Prospectus dated February&nbsp;15, 2024, and each &#147;<B>free-writing prospectus</B>&#148; (as defined pursuant to Rule 405 under the Securities
Act) listed on <U>Annex B</U> hereto as constituting part of the Time of Sale Information. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2. <U>Purchase of the Securities by the
Underwriters</U>. (a)&nbsp;The Company, on the basis of the representations, warranties and agreements set forth herein and subject to the conditions set forth herein, agrees to issue and sell the Securities to the several Underwriters as provided
in this Agreement, and each Underwriter, on the basis of the representations, warranties and agreements set forth herein and subject to the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
conditions set forth herein, agrees, severally and not jointly, to purchase from the Company the respective principal amount of Securities set forth opposite such Underwriter&#146;s name in
Schedule 1 hereto at a price equal to 99.161% of the principal amount of the Securities, plus accrued interest, if any, from February&nbsp;20, 2024 to the Closing Date (as defined below). The Company will not be obligated to deliver any of the
Securities except upon payment for all the Securities to be purchased as provided herein. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) The Company understands that the
Underwriters intend to make a public offering of the Securities as soon after the effectiveness of this Agreement as in the judgment of the Representatives is advisable, and initially to offer the Securities on the terms set forth in the Time of
Sale Information. The Company acknowledges and agrees that the Underwriters may offer and sell Securities to or through any affiliate of an Underwriter and that any such affiliate may offer and sell Securities purchased by it to or through any
Underwriter. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) Payment for and delivery of the Securities will be made at Davis Polk&nbsp;&amp; Wardwell LLP at 8:30 A.M., New York
City time, on February&nbsp;20, 2024, or at such other time or place on the same or such other date, not later than the fifth business day thereafter, as the Representatives and the Company may agree upon in writing. The time and date of such
payment and delivery is referred to herein as the &#147;<B>Closing</B> <B>Date</B>&#148;. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) Payment for the Securities shall be made by
wire transfer in immediately available funds to the account(s) specified by the Company to the Representatives against delivery to the nominee of The Depository Trust Company (&#147;<B>DTC</B>&#148;), for the account of the Underwriters, of one or
more global notes representing the Securities (collectively, the &#147;<B>Global</B> <B>Notes</B>&#148;), with any transfer taxes payable in connection with the sale of the Securities duly paid by the Company. The Global Notes will be made available
for inspection by the Representatives not later than 1:00 P.M., New York City time, on the business day prior to the Closing Date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e)
The Company acknowledges and agrees that the Underwriters are acting solely in the capacity of an arm&#146;s length contractual counterparty to the Company with respect to the offering of Securities contemplated hereby (including in connection with
determining the terms of the offering) and not as a financial advisor or a fiduciary to, or an agent of, the Company or any other person. Additionally, neither the Representatives nor any other Underwriter is advising the Company or any other person
as to any legal, tax, investment, accounting or regulatory matters in any jurisdiction. The Company shall consult with its own advisors concerning such matters and shall be responsible for making its own independent investigation and appraisal of
the transactions contemplated hereby, and the Underwriters shall have no responsibility or liability to the Company with respect thereto. Any review by the Underwriters of the Company, the transactions contemplated hereby or other matters relating
to such transactions will be performed solely for the benefit of the Underwriters and shall not be on behalf of the Company. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3. <U>Representations and Warranties of the Company</U>. The Company represents and warrants
to each Underwriter that: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) <I>Preliminary Prospectus.</I> No order preventing or suspending the use of any Preliminary Prospectus has
been issued by the Commission, and each Preliminary Prospectus, at the time of filing thereof, complied in all material respects with the Securities Act and did not contain any untrue statement of a material fact or omit to state a material fact
required to be stated therein or necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading; <U>provided</U> that the Company makes no representation or warranty with respect to
any statements or omissions made in reliance upon and in conformity with information relating to any Underwriter furnished to the Company in writing by such Underwriter through the Representatives expressly for use in any Preliminary Prospectus, it
being understood and agreed that the only such information consists of the information set forth in Section&nbsp;7(b) hereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) <I>Time
of Sale Information</I>. The Time of Sale Information, at the Time of Sale, did not, and at the Closing Date will not, contain any untrue statement of a material fact or omit to state a material fact necessary in order to make the statements
therein, in the light of the circumstances under which they were made, not misleading; <U>provided</U> that the Company makes no representation or warranty with respect to any statements or omissions made in reliance upon and in conformity with
information relating to any Underwriter furnished to the Company in writing by such Underwriter through the Representatives expressly for use in such Time of Sale Information, it being understood and agreed that the only such information consists of
the information set forth in Section&nbsp;7(b) hereof. No statement of material fact included in the Prospectus has been omitted from the Time of Sale Information and no statement of material fact included in the Time of Sale Information that is
required to be included in the Prospectus has been omitted therefrom. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) <I>Issuer</I> <I>Free Writing Prospectus. </I>The Company
(including its agents and representatives, other than the Underwriters in their capacity as such) has not prepared, made, used, authorized, approved or referred to, and will not prepare, make, use, authorize, approve or refer to, any &#147;written
communication&#148; (as defined in Rule 405 under the Securities Act) that constitutes an offer to sell or solicitation of an offer to buy the Securities (each such communication by the Company or its agents and representatives (other than a
communication referred to in clauses (i)&nbsp;(ii) and (iii) below), an &#147;<B>Issuer Free Writing Prospectus</B>&#148;) other than (i)&nbsp;any document not constituting a prospectus pursuant to Section&nbsp;2(a)(10)(a) of the Securities Act or
Rule 134 under the Securities Act, (ii)&nbsp;the Preliminary Prospectus, (iii)&nbsp;the Prospectus, (iv)&nbsp;the documents listed on <U>Annex B</U> hereto as constituting part of the Time of Sale Information and (v)&nbsp;any electronic road show or
other written communications, in each case approved in writing in advance by the Representatives (such approval not to be unreasonably withheld). Each such Issuer Free Writing Prospectus complies in all material respects with the Securities Act, has
been or will be (within the time period specified in Rule 433) filed in accordance with the Securities Act (to the extent required thereby) and, when taken together with the Preliminary Prospectus accompanying, or
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
delivered prior to delivery of, or filed prior to the first use of, such Issuer Free Writing Prospectus, did not, and at the Closing Date will not, contain any untrue statement of a material fact
or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading; <U>provided</U> that the Company makes no representation or warranty with respect to
any statements or omissions made in each such Issuer Free Writing Prospectus in reliance upon and in conformity with information relating to any Underwriter furnished to the Company in writing by such Underwriter through the Representatives
expressly for use in any Issuer Free Writing Prospectus, it being understood and agreed that the only such information consists of the information set forth in Section&nbsp;7(b) hereof. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) <I>Registration Statement and Prospectus.</I> The Registration Statement is an &#147;automatic shelf registration statement&#148; as
defined under Rule 405 of the Securities Act that has been filed with the Commission not earlier than three years prior to the date hereof; and no notice of objection of the Commission to the use of such registration statement or any post-effective
amendment thereto pursuant to Rule 401(g)(2) under the Securities Act has been received by the Company. No order suspending the effectiveness of the Registration Statement has been issued by the Commission and no proceeding for that purpose or
pursuant to Section&nbsp;8A of the Securities Act against the Company or related to the offering of Securities contemplated hereby has been initiated or, to the knowledge of the Company, threatened by the Commission; as of the applicable effective
date of the Registration Statement and any amendment thereto, the Registration Statement complied and will comply in all material respects with the Securities Act, and the Trust Indenture Act of 1939, as amended, and the rules and regulations of the
Commission thereunder (collectively, the &#147;<B>Trust Indenture Act</B>&#148;), and did not and will not contain any untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary to make the
statements therein not misleading; and as of the date of the Prospectus and any amendment or supplement thereto through and as of the Closing Date, the Prospectus did not and will not contain any untrue statement of a material fact or omit to state
a material fact required to be stated therein or necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading; <U>provided</U> that the Company makes no representation or warranty
with respect to (i)&nbsp;that part of the Registration Statement that constitutes the Statement of Eligibility and Qualification (Form <FONT STYLE="white-space:nowrap">T-1)</FONT> of the Trustee under the Trust Indenture Act or (ii)&nbsp;any
statements or omissions made in reliance upon and in conformity with information relating to any Underwriter furnished to the Company in writing by such Underwriter through the Representatives expressly for use in the Registration Statement and the
Prospectus and any amendment or supplement thereto, it being understood and agreed that the only such information consists of the information set forth in Section&nbsp;7(b) hereof. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) <I>Incorporated Documents.</I> The Company&#146;s documents incorporated by reference in the Registration Statement, the Prospectus and
the Time of Sale Information, when they became effective or were filed with the Commission, as the case may be, conformed in all material respects to the requirements of the Exchange Act, and none of such documents, taken as a whole, contained any
untrue statement of a </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
material fact or omitted to state a material fact required to be stated therein, or necessary to make the statements therein, in the light of the circumstances under which they were made, not
misleading; and during the Prospectus Delivery Period (as defined below) any further documents of the Company so filed and incorporated by reference in the Registration Statement, the Prospectus and the Time of Sale Information, or any further
amendment or supplement thereto, when such documents become effective or are filed with the Commission, as the case may be, will conform in all material respects to the requirements of the Securities Act or the Exchange Act, as applicable, and when
taken together will not contain any untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary to make the statements therein, in the light of the circumstances under which they were made, not
misleading; provided, however, that this representation and warranty shall not apply to any statements or omissions made in reliance upon and in conformity with information furnished in writing to the Company by an Underwriter through the
Representatives expressly for use therein, it being understood and agreed that the only such information consists of the information set forth in Section&nbsp;7(b) hereof. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f) <I>Financial Statements.</I> The financial statements and the related notes thereto with respect to the Company and its consolidated
subsidiaries included or incorporated by reference in the Registration Statement, the Time of Sale Information and the Prospectus comply in all material respects with the applicable requirements of the Securities Act and the Exchange Act, as
applicable, and present fairly, in all material respects, the financial position of the Company and its consolidated subsidiaries as of the dates indicated and the statements of earnings, comprehensive earnings and retained earnings, and statements
of cash flows for the periods specified; such financial statements have been prepared in conformity with generally accepted accounting principles applied on a consistent basis throughout the periods covered thereby, and the summary historical
consolidated financial data included or incorporated by reference in the Registration Statement, the Time of Sale Information and the Prospectus presents fairly, in all material respects, the information shown therein and have been compiled on a
basis consistent with that of the related financial statements incorporated by reference in the Registration Statement, the Time of Sale Information and the Prospectus. The interactive data in eXtensible Business Reporting Language included or
incorporated by reference in the Registration Statement, the Time of Sale Information and the Prospectus fairly presents the information called for in all material respects and is prepared in accordance with the Commission&#146;s rules and
guidelines applicable thereto. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(g) <I>No Material Adverse Change.</I> Neither the Company nor any of its subsidiaries has sustained since
the date of the latest audited financial statements included or incorporated by reference in the Registration Statement, the Time of Sale Information and the Prospectus any material loss or interference with its business from fire, explosion, flood
or other calamity, whether or not covered by insurance, or from any labor dispute or court or governmental action, order or decree which would be reasonably likely to have a material adverse effect on the financial position, stockholders&#146;
equity, results of operations or business prospects of the Company and its subsidiaries taken as a whole (a &#147;<B>Material Adverse Effect</B>&#148;), otherwise than as set forth </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
or contemplated in the Registration Statement, the Time of Sale Information and the Prospectus; and, since the respective dates as of which information is given in the Registration Statement, the
Time of Sale Information and the Prospectus, there has not been any change in the capital stock (other than pursuant to options, stock purchase and other employee benefit plans and the Company&#146;s stock
<FONT STYLE="white-space:nowrap">buy-back</FONT> program) or long-term debt of the Company and its subsidiaries taken as a whole or any material adverse change, or any development involving a prospective material adverse change, in or affecting the
general affairs, management, financial position, stockholders&#146; equity or results of operations of the Company and its subsidiaries taken as a whole, in each case, otherwise than as set forth or contemplated in the Registration Statement, the
Time of Sale Information and the Prospectus. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(h) <I>Organization and Good Standing.</I> The Company has been duly incorporated and is
validly existing as a corporation in good standing under the laws of the State of Delaware, with corporate power and authority to own its properties and conduct its business as described in the Registration Statement, the Time of Sale Information
and the Prospectus, and has been duly qualified as a foreign corporation for the transaction of business and is in good standing under the laws of each other jurisdiction in which it owns or leases properties, or conducts any business, so as to
require such qualification, or is subject to no material liability or disability by reason of the failure to be so qualified in any such jurisdiction; and each subsidiary of the Company has been duly incorporated or otherwise organized and is
validly existing as a corporation or other entity in good standing under the laws of its jurisdiction of incorporation or organization, with power and authority (corporate and other) to own and conduct its properties and conduct its business as
currently conducted, and has been duly qualified as a foreign corporation or other entity for the transaction of business and is in good standing under the laws of each other jurisdiction in which it owns or leases properties, or conducts any
business, so as to require such qualification, or is subject to no liability or disability by reason of the failure to be so qualified in any such jurisdiction, except where the failure to be would not, individually or in the aggregate, result in a
Material Adverse Effect. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) <I>Capitalization.</I> The Company has the authorized capitalization as set forth in the Registration
Statement, the Time of Sale Information and the Prospectus, and all of the issued shares of capital stock of the Company and its subsidiaries have been duly and validly authorized and issued and are fully paid and
<FONT STYLE="white-space:nowrap">non-assessable;</FONT> and all of the issued shares of capital stock of each subsidiary of the Company that are owned by the Company are owned directly or indirectly by the Company, free and clear of all liens,
encumbrances, equities or claims. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(j) <I>Due Authorization.</I> The Company has full right, power and authority to execute and deliver
this Agreement and the Securities, and to perform its obligations hereunder, thereunder and under the Indenture (collectively, the &#147;<B>Transaction</B> <B>Documents</B>&#148;); and all action required to be taken for the due and proper
authorization, execution and delivery of each of the Transaction Documents and the consummation of the transactions contemplated thereby has been duly and validly taken. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(k) <I>The Securities and the Indenture. </I>The Securities have been duly authorized and,
when issued and delivered pursuant to this Agreement and the Indenture, will have been duly executed, authenticated, issued and delivered and will constitute valid and legally binding obligations of the Company entitled to the benefits provided by
the Indenture; the Indenture has been duly authorized, executed and delivered by the Company and duly qualified under the Trust Indenture Act and constitutes a valid and legally binding instrument, enforceable against the Company in accordance with
its terms, subject, as to enforcement, to bankruptcy, insolvency, reorganization and other laws of general applicability relating to or affecting creditors&#146; rights and to general equity principles (collectively, the &#147;<B>Enforceability
Exceptions</B>&#148;); and the Indenture conforms, and the Securities will conform, to the descriptions thereof in the Registration Statement, the Time of Sale Information and the Prospectus as amended or supplemented. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(l) <I>Underwriting Agreement</I>. This Agreement has been duly authorized, executed and delivered by the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(m) <I>[Reserved].</I> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(n)
<I>No Conflict; No Consent Required. </I>The issue and sale of the Securities and the compliance by the Company with all of the provisions of each of the Transaction Documents and the consummation of the transactions contemplated by the Transaction
Documents will not conflict with or result in a breach or violation of any of the terms or provisions of, or constitute a default under, any indenture, mortgage, deed of trust, loan agreement or other agreement or instrument to which the Company or
any of its subsidiaries is a party or by which the Company or any of its subsidiaries is bound or to which any of the property or assets of the Company or any of its subsidiaries is subject except, in each case, for such breaches, violations and
defaults that would not, individually or in the aggregate, be reasonably likely to have a Material Adverse Effect, nor will such action result in any violation of (i)&nbsp;the provisions of the Amended and Restated Certificate of Incorporation or
Amended and Restated Bylaws of the Company or (ii)&nbsp;any statute or any order, rule or regulation of any court or governmental agency or body having jurisdiction over the Company or any of its subsidiaries or any of their properties, except, in
the case of clause (ii)&nbsp;above, for such violations that would not, individually or in the aggregate, result in a Material Adverse Effect; and no consent, approval, authorization, order, registration or qualification of or with any court or
governmental agency or body is required for the issue and sale of the Securities or the consummation by the Company of the transactions contemplated by the Transaction Documents, except the registration under the Securities Act of the Securities,
such as have been obtained under the Trust Indenture Act, and such consents, approvals, authorizations, registrations or qualifications as may be required under state securities laws or Blue Sky laws in connection with the purchase and distribution
of the Securities by the Underwriters. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(o) <I>Legal Proceedings.</I> Other than as set forth in the Registration Statement, the
Time of Sale Information and the Prospectus, there are no known legal or governmental proceedings pending to which the Company or any of its subsidiaries is a party or of which any property of the Company or any of its subsidiaries is the subject
which would, individually or in the aggregate, be reasonably likely to have a Material Adverse Effect; and, to the Company&#146;s knowledge, no such proceedings are threatened or contemplated by governmental authorities or threatened by others. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(p) <I>Independent Accountant.</I> PricewaterhouseCoopers LLP, which has audited certain financial statements of the Company and its
subsidiaries is, to our knowledge, an independent registered public accounting firm with respect to the Company and its subsidiaries within the applicable rules and regulations adopted by the Commission and the Public Company Accounting Oversight
Board (United States) and as required by the Securities Act. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(q) <I>Title to Real and Personal Property.</I> The Company and its
subsidiaries have good and marketable title in fee simple to all real property and good and marketable title to all personal property owned by them, in each case free and clear of all liens, encumbrances and defects except such as are described in
the Registration Statement, the Time of Sale Information and the Prospectus or such as are not material and do not interfere with the use made and proposed to be made of such property by the Company and its subsidiaries; and any real property and
buildings held under lease by the Company and its subsidiaries are held by them under valid, subsisting and enforceable leases with such exceptions as are not material and do not interfere with the use made and proposed to be made of such property
and buildings by the Company and its subsidiaries. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(r) <I>Title to Intellectual Property.</I> The Company and its subsidiaries own or
possess the patents, patent rights, licenses, inventions, copyrights, <FONT STYLE="white-space:nowrap">know-how</FONT> (including trade secrets and other unpatented and/or unpatentable proprietary or confidential information, systems or procedures),
trademarks, service marks and trade names (collectively, &#147;<B>patent and proprietary rights</B>&#148;) presently employed by them in connection with the business now operated by them, and the patent and proprietary rights necessary in connection
with the business proposed to be operated by them, as described in the Registration Statement, the Time of Sale Information and the Prospectus, and neither the Company nor any of its subsidiaries has received any notice or is otherwise aware of any
infringement of or conflict with asserted rights of others with respect to any patent or proprietary rights referred to above, or of any facts which would render any such patent and proprietary rights invalid or inadequate to protect the interest of
the Company or any of its subsidiaries therein, and which infringement or conflict (if the subject of any unfavorable decision, ruling or finding) or invalidity or inadequacy, would, individually or in the aggregate, be reasonably likely to have a
Material Adverse Effect. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(s) <I>Investment Company Act.</I> The Company is not and, upon the issuance and sale of the Securities and the
application of the proceeds thereof as described in the Registration Statement, the Time of Sale Information and the Prospectus, will not be required to register as an &#147;investment company&#148; or an entity &#147;controlled&#148; by an
&#147;investment company&#148; (as such terms are defined in the Investment Company Act of 1940) and the rules and regulations of the Commission thereunder (collectively, the &#147;<B>Investment Company Act</B>&#148;). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(t) <I>Licenses and Permits.</I> Except as would not, individually or in the aggregate,
result in a Material Adverse Effect, each of the Company and its subsidiaries owns or possesses all licenses, certificates, permits and other authorizations issued by the appropriate federal, state, local or foreign governmental or regulatory
authorities that are necessary for the ownership or lease of their respective properties or the conduct of their respective businesses as described in the Registration Statement, the Time of Sale Information and the Prospectus; and except as
described in the Registration Statement, the Time of Sale Information and the Prospectus, neither the Company nor any of its subsidiaries has received notice of any revocation or modification of any such license, certificate, permit or authorization
or has any reason to believe that any such license, certificate, permit or authorization could not be renewed in the ordinary course. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(u)
<I>Compliance With Environmental Laws.</I> Except as described in the Registration Statement, the Time of Sale Information and the Prospectus, neither the Company nor any of its subsidiaries (i)&nbsp;has received notice or has knowledge of any
claim, demand, obligation, cause of action, accusation, allegation, order, violation, damage, injury, judgment, penalty or fine which would, individually or in the aggregate, be reasonably likely to have a Material Adverse Effect resulting from
(A)&nbsp;the violation or alleged violation of any laws relating to air pollution, water pollution, noise control and/or handling discharge, disposal or recovery of <FONT STYLE="white-space:nowrap">on-site</FONT> or
<FONT STYLE="white-space:nowrap">off-site</FONT> hazardous substances or materials, (B)&nbsp;any noncompliance with or violation of the requirements of any environmental law, (C)&nbsp;the release or threatened release of any toxic or hazardous
waste, substance or constituent or (D)&nbsp;any other Environmental Matter (as hereinafter defined), (ii) is liable, or has any contingent liability known to the Company, in connection with the release or threatened release of any toxic or hazardous
waste, substance or constituent, which liability would, individually or in the aggregate, be reasonably likely to have a Material Adverse Effect, or (iii)&nbsp;has received notice or has actual knowledge of any governmental investigation seeking
remedial action in connection with a release or threatened release of any toxic or hazardous waste, substance or constituent for which the Company or any of its subsidiaries may be liable and which (if the Company or any of its subsidiaries were so
liable) would be reasonably likely to have a Material Adverse Effect. &#147;<B>Environmental</B> <B>Matter</B>&#148; means (I)&nbsp;the release of any amount of toxic or hazardous waste or substances, pollutant or contaminant into the environment,
(II)&nbsp;the management, including the generation, handling, treatment, storage, transport, discharge or disposal or recovery, whether <FONT STYLE="white-space:nowrap">on-site</FONT> or <FONT STYLE="white-space:nowrap">off-site,</FONT> of any solid
wastes, toxic or hazardous wastes, hazardous substances, pollutants or contaminants, (III)&nbsp;the past and present use of surface waters or groundwater and (IV)&nbsp;the construction or maintenance of any dams or levees. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(v) <I>Disclosure Controls</I>. The Company maintains an effective system of &#147;disclosure controls and procedures&#148; (as defined in
Rule <FONT STYLE="white-space:nowrap">13a-15(e)</FONT> of the Exchange Act) that is designed to ensure that information required to be disclosed by the Company in reports that it files or submits under the Exchange Act is recorded, processed,
summarized and reported within the time periods specified in the Commission&#146;s rules </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
and forms, including controls and procedures designed to ensure that such information is accumulated and communicated to the Company&#146;s management as appropriate to allow timely decisions
regarding required disclosure. The Company has carried out evaluations of the effectiveness of its disclosure controls and procedures as required by Rule <FONT STYLE="white-space:nowrap">13a-15</FONT> of the Exchange Act. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(w) <I>Accounting Controls.</I> The Company maintains a system of &#147;internal control over financial reporting&#148; (as defined in Rule <FONT
STYLE="white-space:nowrap">13a-15(f)</FONT> of the Exchange Act) that complies with the requirements of the Exchange Act. There are no material weaknesses in the Company&#146;s internal control over financial reporting. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(x) <I>No Unlawful Payments.</I> Neither the Company nor any of its subsidiaries nor, to the knowledge of the Company, any director, officer,
agent, employee or other person associated with or acting on behalf of the Company or any of its subsidiaries has (i)&nbsp;used any corporate funds for any unlawful contribution, gift, entertainment or other unlawful expense relating to political
activity; (ii)&nbsp;made any direct or indirect unlawful payment to any foreign or domestic government official or employee from corporate funds; (iii)&nbsp;violated or is in violation of any provision of the U.S. Foreign Corrupt Practices Act of
1977, as amended, or the U.K. Bribery Act 2010; or (iv)&nbsp;made any bribe, rebate, payoff, influence payment, kickback or other unlawful payment. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(y) <I>Compliance with Anti-Money Laundering Laws</I>. The operations of the Company and its subsidiaries are and have been conducted at all
times in compliance with applicable financial recordkeeping and reporting requirements of the Currency and Foreign Transactions Reporting Act of 1970, as amended, the money laundering statutes of all jurisdictions, the rules and regulations
thereunder and any related or similar rules, regulations or guidelines, issued, administered or enforced by any governmental agency (collectively, the &#147;<B>Anti-Money Laundering Laws</B>&#148;), and no action, suit or proceeding by or before any
court or governmental agency, authority or body or any arbitrator involving the Company or any of its subsidiaries with respect to the Anti-Money Laundering Laws is pending or, to the knowledge of the Company, threatened. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(z) <I>Compliance with OFAC. </I>None of the Company, any of its subsidiaries or, to the knowledge of the Company, any director, officer,
agent, employee or affiliate of the Company or any of its subsidiaries is currently subject to any sanctions administered by the Office of Foreign Assets Control of the U.S. Department of the Treasury (&#147;<B>OFAC</B>&#148;), the United Nations
Security Council (&#147;<B>UNSC</B>&#148;), the European Union, HM Treasury (&#147;<B>HMT</B>&#148;), or other relevant sanctions authority (collectively, &#147;<B>Sanctions</B>&#148;); and the Company will not directly or indirectly use the
proceeds of the offering of the Securities hereunder, or lend, contribute or otherwise make available such proceeds to any subsidiary, joint venture partner or other person or entity, for the purpose of financing the activities of any person
currently subject to any Sanctions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(aa) <I>Sarbanes-Oxley Act</I>. There is and has been no failure on the part of the Company or any of
the Company&#146;s directors or officers, in their capacities as such, to comply in all material respects with any provision of the Sarbanes-Oxley Act of 2002 and the rules and regulations promulgated in connection therewith, including
Section&nbsp;402 related to loans and Sections 302 and 906 related to certifications. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(bb) <I>No Stabilization.</I> The Company has not taken, directly or indirectly, any action
designed to or that could reasonably be expected to cause or result in any stabilization or manipulation of the price of the Securities. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(cc) <I>Margin Rules</I>. Neither the issuance, sale and delivery of the Securities nor the application of the proceeds thereof by the Company
as described in the Registration Statement, the Time of Sale Information and the Prospectus will violate Regulation T, U or X of the Board of Governors of the Federal Reserve System or any other regulation of such Board of Governors. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(dd) <I>Status under the Securities Act</I>. The Company is not (and at all times relevant to the offer and sale of the Securities has not
been) an &#147;ineligible issuer,&#148; and is (and at all times relevant to the offer and sale of the Securities has been) a &#147;well-known seasoned issuer,&#148; in each case as defined in the Securities Act. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ee) <I>Cybersecurity. </I>(i)(x) Except as disclosed in the Registration Statement, the Time of Sale Information and the Prospectus, to the
knowledge of the Company, there has been no material security breach or incident involving unauthorized access or disclosure of any of the Company&#146;s or any of its subsidiaries&#146; information technology and computer systems, networks,
hardware, software, data (including the data of their respective customers, employees, suppliers, vendors and any third party data maintained by or on behalf of them), equipment or technology (collectively, &#147;<B>IT Systems and Data</B>&#148;)
and (y)&nbsp;the Company and its subsidiaries have not been notified of, and have no knowledge of any event or condition that would reasonably be expected to result in, any material security breach or other compromise to their IT Systems and Data;
(ii)&nbsp;the Company and its subsidiaries are presently in compliance with all applicable laws or statutes and all judgments, orders, rules and regulations of any court or arbitrator or governmental or regulatory authority, internal policies and
contractual obligations relating to the privacy and security of IT Systems and Data and to the protection of such IT Systems and Data from unauthorized use, access, misappropriation or modification, except as would not, in the case of this clause
(ii), individually or in the aggregate, have a Material Adverse Effect; and (iii)&nbsp;the Company and its subsidiaries have implemented backup and disaster recovery technology which, in the Company&#146;s reasonable judgment, are reasonably
adequate to protect its and its subsidiaries&#146; business having regard to industry standards and practices. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4. <U>Further Agreements
of the Company</U>. The Company covenants and agrees with each Underwriter that: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) <I>Required Filings.</I> The Company will file the
final Prospectus with the Commission within the time periods specified by Rule 424(b) and Rule 430A or 430B under the Securities Act, will file any Issuer Free Writing Prospectus (including the Term Sheet in the form of <U>Annex C</U> hereto) to the
extent required by Rule 433 under the Securities Act; and will file promptly all reports and any definitive proxy or information </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
statements required to be filed by the Company with the Commission pursuant to Section&nbsp;13(a), 13(c), 14 or 15(d) of the Exchange Act subsequent to the date of the Prospectus and for so long
as the delivery of a prospectus is required in connection with the offering or sale of the Securities; and the Company will furnish copies of the Prospectus and each Issuer Free Writing Prospectus (to the extent not previously delivered) to the
Underwriters in New York City on the business day next succeeding the date of this Agreement in such quantities as the Representatives may reasonably request. The Company will pay the registration fees for this offering within the time period
required by Rule 456(b)(1)(i) under the Securities Act (without giving effect to the proviso therein) and in any event prior to the Closing Date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) <I>Delivery of Copies.</I> The Company will deliver, without charge, (i)&nbsp;to the Representatives, conformed copies of the Registration
Statement as originally filed and each amendment thereto dated on or prior to the Closing Date, in each case including all exhibits and consents filed therewith and documents incorporated by reference therein; and (ii)&nbsp;to each Underwriter
(A)&nbsp;a conformed copy of the Registration Statement as originally filed and each amendment thereto dated on or prior to the Closing Date, in each case including all exhibits and consents filed therewith and (B)&nbsp;during the Prospectus
Delivery Period (as defined below), as many copies of the Prospectus (including all amendments and supplements thereto and documents incorporated by reference therein) and each Issuer Free Writing Prospectus as the Representatives may reasonably
request. Notwithstanding the foregoing, the Company will not be required to deliver conformed copies of the Registration Statement as described in clauses (b)(i) and (ii)(A) above, provided that such documents are available electronically through
the Commission&#146;s EDGAR system. As used herein, the term &#147;Prospectus Delivery Period&#148; means such period of time after the first date of the public offering of the Securities as in the opinion of counsel for the Underwriters a
prospectus relating to the Securities is required by law to be delivered (or required to be delivered but for Rule 172 under the Securities Act) in connection with sales of the Securities by any Underwriter or dealer. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) <I>Amendments or Supplements; Issuer Free Writing Prospectuses.</I> Before making, preparing, using, authorizing, approving, referring to
or filing any Issuer Free Writing Prospectus, and before filing any amendment or supplement to the Registration Statement or the Prospectus, the Company will furnish to the Representatives and counsel for the Underwriters a copy of the proposed
Issuer Free Writing Prospectus, amendment or supplement for review and will not make, prepare, use, authorize, approve, refer to or file any such Issuer Free Writing Prospectus or file any such proposed amendment or supplement to which the
Representatives reasonably objects, provided, however, following the Closing Date, the foregoing requirements shall not apply to any of the Company&#146;s reports filed with the Commission required to be filed pursuant to Section&nbsp;13(a) or 15(d)
of the Exchange Act, copies of which filings the Company will cause to be delivered to the Representatives promptly after being transmitted for filing with the Commission unless such filings are available electronically through the Commission&#146;s
EDGAR system. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) <I>Notice to the Representatives.</I> The Company will advise the Representatives
promptly, and confirm such advice in writing, (i)&nbsp;when any amendment to the Registration Statement has been filed or becomes effective; (ii)&nbsp;when any supplement to the Prospectus or any amendment to the Prospectus or any Issuer Free
Writing Prospectus has been filed during the Prospectus Delivery Period; (iii)&nbsp;of any request by the Commission for any amendment to the Registration Statement or any amendment or supplement to the Prospectus or the receipt of any comments from
the Commission relating to the Registration Statement or any other request by the Commission for any additional information in connection with this offering of Securities; (iv)&nbsp;of the issuance by the Commission of any order suspending the
effectiveness of the Registration Statement or preventing or suspending the use of any Preliminary Prospectus or the Prospectus or the initiation or threatening of any proceeding for that purpose or pursuant to Section&nbsp;8A of the Securities Act
during the Prospectus Delivery Period; (v)&nbsp;of the occurrence of any event within the Prospectus Delivery Period as a result of which the Prospectus, the Time of Sale Information or any Issuer Free Writing Prospectus as then amended or
supplemented would include any untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary in order to make the statements therein, in the light of the circumstances existing when the Prospectus,
the Time of Sale Information or any such Issuer Free Writing Prospectus, as applicable, is delivered to a purchaser, not misleading; (vi)&nbsp;of the receipt by the Company of any notice of objection of the Commission to the use of the Registration
Statement or any post-effective amendment thereto pursuant to Rule 401(g)(2) under the Securities Act during the Prospectus Delivery Period; and (vii)&nbsp;of the receipt by the Company of any notice with respect to any suspension of the
qualification of the Securities for offer and sale in any jurisdiction or the initiation or threatening of any proceeding for such purpose; and the Company will use its reasonable best efforts to prevent the issuance of any such order suspending the
effectiveness of the Registration Statement, preventing or suspending the use of any Preliminary Prospectus or the Prospectus or suspending any such qualification of the Securities and, if any such order is issued, will use its reasonable best
efforts to obtain as soon as possible thereafter the withdrawal thereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) <I>Time of Sale Information.</I> If at any time prior to the
Closing Date (i)&nbsp;any event shall occur or condition shall exist as a result of which the Time of Sale Information as then amended or supplemented would include any untrue statement of a material fact or omit to state any material fact necessary
in order to make the statements therein, in the light of the circumstances, not misleading or (ii)&nbsp;it is necessary to amend or supplement the Time of Sale Information to comply with law, the Company will immediately notify the Underwriters
thereof and forthwith prepare and, subject to paragraph (c)&nbsp;above, file with the Commission (to the extent required) and furnish to the Underwriters and to such dealers as the Representatives may designate, such amendments or supplements to the
Time of Sale Information as may be necessary so that the statements in the Time of Sale Information as so amended or supplemented will not, in the light of the circumstances under which they were made, be misleading or so that the Time of Sale
Information will comply with law. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">14 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f) <I>Ongoing Compliance</I>. If during the Prospectus Delivery Period (i)&nbsp;any event
shall occur or condition shall exist as a result of which the Prospectus as then amended or supplemented would include any untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary in order to
make the statements therein, in the light of the circumstances existing when the Prospectus is delivered to a purchaser, not misleading or (ii)&nbsp;it is necessary to amend or supplement the Prospectus to comply with law, the Company will
immediately notify the Underwriters thereof and forthwith prepare and, subject to paragraph (c)&nbsp;above, file with the Commission and furnish to the Underwriters and to such dealers as the Representatives may designate, such amendments or
supplements to the Prospectus as may be necessary so that the statements in the Prospectus as so amended or supplemented will not, in the light of the circumstances existing when the Prospectus is delivered to a purchaser, be misleading or so that
the Prospectus will comply with law.<I> </I> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(g)<I> Blue Sky Compliance.</I> The Company will qualify the Securities for offer and sale
under the securities or Blue Sky laws of such jurisdictions as the Representatives shall reasonably request and will continue such qualifications in effect so long as required for distribution of the Securities; <U>provided</U> that the Company
shall not be required to (i)&nbsp;qualify as a foreign corporation or other entity or as a dealer in securities in any such jurisdiction where it would not otherwise be required to so qualify, (ii)&nbsp;file any general consent to service of process
in any such jurisdiction or (iii)&nbsp;subject itself to taxation in any such jurisdiction if it is not otherwise so subject. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(h)
<I>Earning Statement. </I>The Company will make generally available to its security holders and the Representatives as soon as practicable an earning statement that satisfies the provisions of Section&nbsp;11(a) of the Securities Act and Rule 158 of
the Commission promulgated thereunder covering a period of at least twelve months beginning with the first fiscal quarter of the Company occurring after the &#147;effective date&#148; (as defined in Rule 158) of the Registration Statement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) <I>Clear Market.</I> During the period from the date hereof through and including the business day following the Closing Date, the Company
will not, without the prior written consent of the Representatives, offer for sale, sell, contract to sell or otherwise dispose of any debt securities issued or guaranteed by the Company and having a tenor of more than one year. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(j) <I>Use of Proceeds.</I> The Company will apply the net proceeds from the sale of the Securities as described in the Registration
Statement, the Time of Sale Information and the Prospectus under the heading &#147;Use of Proceeds&#148;. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(k)<I> DTC</I>. The Company
will assist the Underwriters in arranging for the Securities to be eligible for clearance and settlement through DTC. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(l) <I>No
Stabilization.</I> The Company will not take, directly or indirectly, any action designed to or that could reasonably be expected to cause or result in any stabilization or manipulation of the price of the Securities. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">15 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(m) <I>Record Retention</I>. The Company will, pursuant to reasonable procedures developed
in good faith, retain copies of each Issuer Free Writing Prospectus that is not filed with the Commission in accordance with Rule 433 under the Securities Act. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(n) <I>Reports</I>. The Company, during the Prospectus Delivery Period, will file all documents required to be filed with the Commission
pursuant to the Exchange Act within the time periods required by the Exchange Act. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5. <U>Certain Agreements of the Underwriters</U>. Each
Underwriter hereby represents and agrees that: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) It has not and will not use, authorize use of, refer to, or participate in the
planning for use of, any &#147;free writing prospectus&#148;, as defined in Rule 405 under the Securities Act (which term includes use of any written information furnished to the Commission by the Company and not incorporated by reference into the
Registration Statement and any press release issued by the Company) other than (i)&nbsp;a free writing prospectus that, solely as a result of use by such underwriter, would not trigger an obligation to file such free writing prospectus with the
Commission pursuant to Rule 433, (ii) any Issuer Free Writing Prospectus listed on <U>Annex B</U> or prepared pursuant to Section&nbsp;3(c) or Section&nbsp;4(c) above (including any electronic road show), or (iii)&nbsp;any free writing prospectus
prepared by such underwriter and approved by the Company in advance in writing (each such free writing prospectus referred to in clauses (i)&nbsp;or (iii), an &#147;<B>Underwriter Free Writing Prospectus</B>&#148;). Notwithstanding the foregoing,
the Underwriters may use a term sheet substantially in the form of <U>Annex C</U> hereto without the consent of the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) It is
not subject to any pending proceeding under Section&nbsp;8A of the Securities Act with respect to the offering of the Securities (and will promptly notify the Company if any such proceeding against it is initiated during the Prospectus Delivery
Period). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6. <U>Conditions of Underwriters&#146; Obligations.</U> The obligation of each Underwriter to purchase Securities on the Closing
Date as provided herein is subject to the performance by the Company of its covenants and other obligations hereunder and to the following additional conditions: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) <I>Registration Compliance; No Stop Order.</I> No order suspending the effectiveness of the Registration Statement shall be in effect, and
no proceeding for such purpose, pursuant to Rule 401(g)(2) or pursuant to Section&nbsp;8A under the Securities Act shall be pending before, or to the knowledge of the Company, threatened by the Commission; the Prospectus and each Issuer Free Writing
Prospectus shall have been timely filed with the Commission under the Securities Act (in the case of an Issuer Free Writing Prospectus, to the extent required by Rule 433 under the Securities Act) and in accordance with Section&nbsp;4(a) hereof; and
all requests by the Commission for additional information shall have been complied with to the reasonable satisfaction of the Representatives. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">16 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) <I>Representations and Warranties.</I> The representations and warranties of the Company
contained herein shall be true and correct on the date hereof and on and as of the Closing Date; and the statements of the Company and its officers made in any certificates delivered pursuant to this Agreement shall be true and correct on and as of
the Closing Date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) <I>No Downgrade.</I> Subsequent to the earlier of (A)&nbsp;the Time of Sale and (B)&nbsp;the execution and delivery
of this Agreement, (i)&nbsp;no downgrading shall have occurred in the rating accorded the Securities or any other debt securities or preferred stock of or guaranteed by the Company or any of its subsidiaries by any &#147;nationally recognized
statistical rating organization&#148;, as such term is defined under Section&nbsp;3(a)(62) under the Exchange Act and (ii)&nbsp;no such organization shall have publicly announced that it has under surveillance or review, or has changed its outlook
with respect to, its rating of the Securities or of any other debt securities or preferred stock issued or guaranteed by the Company or any of its subsidiaries (other than an announcement with positive implications of a possible upgrading). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) <I>No Material Adverse Change.</I> No event or condition of a type described in Section&nbsp;3(g) hereof shall have occurred or shall
exist, which event or condition is not described in the Time of Sale Information (excluding any amendment or supplement thereto) and the Prospectus (excluding any amendment or supplement thereto) and the effect of which in the judgment of the
Representatives makes it impracticable or inadvisable to proceed with the offering, sale or delivery of the Securities on the terms and in the manner contemplated by this Agreement, the Time of Sale Information and the Prospectus. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) <I>Officer&#146;s Certificate.</I> The Representatives shall have received on and as of the Closing Date a certificate of an executive
officer of the Company who has specific knowledge of the Company&#146;s financial matters and is satisfactory to the Representatives (i)&nbsp;confirming that such officer has carefully reviewed the Registration Statement, the Time of Sale
Information and the Prospectus and, to the knowledge of such officer, the representations set forth in Sections 3(b) or 3(d) hereof are true and correct, (ii)&nbsp;confirming that the other representations and warranties of the Company in this
Agreement are true and correct and that the Company has complied with all agreements and satisfied all conditions on its part to be performed or satisfied hereunder at or prior to the Closing Date and (iii)&nbsp;to the effect set forth in paragraphs
(a), (c) and (d)&nbsp;above. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f) <I>Comfort Letters.</I> On the date of this Agreement and on the Closing Date, PricewaterhouseCoopers
LLP shall have furnished to the Representatives, at the request of the Company, letters, dated the respective dates of delivery thereof and addressed to the Underwriters, in form and substance reasonably satisfactory to the Representatives,
containing statements and information of the type customarily included in accountants&#146; &#147;comfort letters&#148; to underwriters with respect to the financial statements and certain financial information contained or incorporated by reference
in the Registration Statement, the Time of Sale Information and the Prospectus; <U>provided</U> that each such letter delivered on the date of this Agreement and the Closing Date, respectively, shall use a
<FONT STYLE="white-space:nowrap">&#147;cut-off&#148;</FONT> date no more than three business days prior to such respective delivery date. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">17 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(g) <I>Opinion and <FONT STYLE="white-space:nowrap">10b-5</FONT> disclosure statement of
Counsel for the Company.</I> Wilmer Cutler Pickering Hale and Dorr LLP, counsel for the Company, shall have furnished to the Representatives, at the request of the Company, their written opinion and <FONT STYLE="white-space:nowrap">10b-5</FONT>
disclosure statement, dated the Closing Date and addressed to the Underwriters, in form and substance reasonably satisfactory to the Representatives, to the effect set forth in <U>Annex <FONT STYLE="white-space:nowrap">A-1</FONT></U> hereto. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(h) <I>Opinion of Legal Officer for the Company</I>. Mark D. Austin, Senior Securities Counsel and Assistant Corporate Secretary of the
Company, shall have furnished to the Representatives, at the request of the Company, his written opinion, dated the Closing Date and addressed to the Underwriters, in form and substance reasonably satisfactory to the Representatives, to the effect
set forth in <U>Annex <FONT STYLE="white-space:nowrap">A-2</FONT></U> hereto. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) <I>Opinion and
<FONT STYLE="white-space:nowrap">10b-5</FONT> disclosure statement of Counsel for the Underwriters.</I> The Representatives shall have received on and as of the Closing Date an opinion and <FONT STYLE="white-space:nowrap">10b-5</FONT> disclosure
statement of Davis Polk&nbsp;&amp; Wardwell LLP, counsel for the Underwriters, with respect to such matters as the Representatives may reasonably request, and such counsel shall have received such documents and information as they may reasonably
request to enable them to pass upon such matters. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(j) <I>No Legal Impediment to Issuance.</I> No action shall have been taken and no
statute, rule, regulation or order shall have been enacted, adopted or issued by any federal, state or foreign governmental or regulatory authority that would, as of the Closing Date, prevent the issuance or sale of the Securities; and no injunction
or order of any federal, state or foreign court shall have been issued that would, as of the Closing Date, prevent the issuance or sale of the Securities. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(k) <I>Good Standing</I>. The Representatives shall have received on or as of the business day prior to the Closing Date satisfactory evidence
of the good standing of the Company in its jurisdiction of incorporation and its good standing in such other jurisdictions as the Representatives may reasonably request, in each case in writing or any standard form of telecommunication from the
appropriate governmental authorities of such jurisdictions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(l) <I>DTC</I>. The Securities shall be eligible for clearance and settlement
through DTC. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(m) <I>Additional Documents.</I> On or prior to the Closing Date, the Company shall have furnished to the Representatives
such further certificates and documents as the Representatives may reasonably request. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">18 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(n) <I>Chief Financial Officer&#146;s Certificate. </I>The Representatives shall have
received on the date of this Agreement and on the Closing Date a certificate signed by the Company&#146;s Chief Financial Officer, dated the respective dates of delivery thereof and addressed to the Representatives, certifying certain disclosure in
the Preliminary Prospectus and Prospectus. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">All opinions, letters, certificates and evidence mentioned above or elsewhere in this
Agreement shall be deemed to be in compliance with the provisions hereof only if they are in form and substance reasonably satisfactory to counsel for the Underwriters. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7. <U>Indemnification and Contribution</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) <I>Indemnification of the Underwriters.</I> The Company agrees to indemnify and hold harmless each Underwriter, its affiliates, selling
agents, directors and officers and each person, if any, who controls such Underwriter within the meaning of Section&nbsp;15 of the Securities Act or Section&nbsp;20 of the Exchange Act, from and against any and all losses, claims, damages and
liabilities (including, without limitation, reasonable and documented legal fees and other expenses incurred in connection with any suit, action or proceeding or any claim asserted, promptly after such fees and expenses are incurred), joint or
several, that arise out of, or are based upon, (i)&nbsp;any untrue statement or alleged untrue statement of a material fact contained in the Registration Statement or caused by any omission or alleged omission to state therein a material fact
required to be stated therein or necessary in order to make the statements therein, not misleading, or (ii)&nbsp;any untrue statement or alleged untrue statement of a material fact contained in the Prospectus (or any amendment or supplement
thereto), any Issuer Free Writing Prospectus or any Time of Sale Information, or caused by any omission or alleged omission to state therein a material fact necessary in order to make the statements therein, in light of the circumstances under which
they were made, not misleading, in each case except insofar as such losses, claims, damages or liabilities arise out of, or are based upon, any untrue statement or omission or alleged untrue statement or omission made in reliance upon and in
conformity with any information relating to any Underwriter furnished to the Company in writing by such Underwriter through the Representatives expressly for use therein, it being understood and agreed that the only such information consists of the
information set forth in Section&nbsp;7(b) hereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) <I>Indemnification of the Company.</I> Each Underwriter agrees, severally and not
jointly, to indemnify and hold harmless the Company, its directors, its officers who signed the Registration Statement and each person, if any, who controls the Company within the meaning of Section&nbsp;15 of the Securities Act or Section&nbsp;20
of the Exchange Act to the same extent as the indemnity set forth in paragraph (a)&nbsp;above, but only with respect to any losses, claims, damages or liabilities (including, without limitation, legal fees and other expenses incurred in connection
with any suit, action or proceeding or any claim asserted, promptly after such fees and expenses are incurred) that arise out of, or are based upon, any untrue statement or omission or alleged untrue statement or omission made in reliance upon and
in conformity with any information relating to such Underwriter furnished to the Company in writing by such Underwriter through the Representatives expressly for use in the Registration Statement, the Prospectus (or any amendment or supplement
thereto), any Issuer Free Writing Prospectus or any Time of Sale Information, it being understood and agreed that the only such information consists </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">19 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
of the following: the third paragraph of text under the caption &#147;Underwriting&#148; in the Preliminary Prospectus and the Prospectus relating to the terms of offering, including the
concession and reallowance to certain dealers, by the Underwriters; the first sentence of the eighth paragraph of text under the caption &#147;Underwriting&#148; in the Preliminary Prospectus and the Prospectus relating to market making by the
Underwriters; and the ninth paragraph of text under the caption &#147;Underwriting&#148; in the Preliminary Prospectus and the Prospectus relating to over-allotment, stabilization and syndicate covering transactions by the Underwriters. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) <I>Notice and Procedures.</I> If any suit, action, proceeding (including any governmental or regulatory investigation), claim or demand
shall be brought or asserted against any person in respect of which indemnification may be sought pursuant to either paragraph (a)&nbsp;or (b) above, such person (the &#147;<B>Indemnified</B> <B>Person</B>&#148;) shall promptly notify the person
against whom such indemnification may be sought (the &#147;Indemnifying Person&#148;) in writing; <U>provided</U> that the failure to notify the Indemnifying Person shall not relieve it from any liability that it may have under this Section&nbsp;7
except to the extent that it has been materially prejudiced (through the forfeiture of substantive rights or defenses) by such failure; and <U>provided</U>, <U>further</U>, that the failure to notify the Indemnifying Person shall not relieve it from
any liability that it may have to an Indemnified Person otherwise than under this Section&nbsp;7. If any such proceeding shall be brought or asserted against an Indemnified Person and it shall have notified the Indemnifying Person thereof, the
Indemnifying Person shall retain counsel reasonably satisfactory to the Indemnified Person (who shall not, without the consent of the Indemnified Person, be counsel to the Indemnifying Person) to represent the Indemnified Person and any others
entitled to indemnification pursuant to Section&nbsp;7 that the Indemnifying Party may designate in such proceeding and shall pay the reasonable and documented fees and expenses of such proceeding and shall pay the fees and expenses of counsel
chosen by the Company related to such proceeding, promptly after incurred. In any such proceeding, any Indemnified Person shall have the right to retain its own counsel, but the fees and expenses of such counsel shall be at the expense of such
Indemnified Person unless (i)&nbsp;the Indemnifying Person and the Indemnified Person shall have mutually agreed to the contrary; (ii)&nbsp;the Indemnifying Person has failed within a reasonable time to retain counsel reasonably satisfactory to the
Indemnified Person; (iii)&nbsp;the Indemnified Person shall have reasonably concluded that there may be legal defenses available to it that are different from or in addition to those available to the Indemnifying Person; or (iv)&nbsp;the named
parties in any such proceeding (including any impleaded parties) include both the Indemnifying Person and the Indemnified Person and representation of both parties by the same counsel would be inappropriate due to actual or potential differing
interests between them. It is understood and agreed that the Indemnifying Person shall not, in connection with any proceeding or related proceeding in the same jurisdiction, be liable for the fees and expenses of more than one separate firm (in
addition to any local counsel) for all Indemnified Persons, and that all such fees and expenses shall be reimbursed promptly after they are incurred. Any such separate firm for any Underwriter, its affiliates, selling agents, directors and officers
and any control persons of such Underwriter shall be designated in writing by the Representatives and any such separate firm for the Company, its directors, its officers who signed the Registration </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">20 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Statement and any control persons of the Company shall be designated in writing by the Company. The Indemnifying Person shall not be liable for any settlement of any proceeding effected without
its written consent, but if settled with such consent or if there be a final judgment for the plaintiff, the Indemnifying Person agrees to indemnify each Indemnified Person from and against any loss or liability by reason of such settlement or
judgment. Notwithstanding the foregoing sentence, if at any time an Indemnified Person shall have requested that an Indemnifying Person reimburse the Indemnified Person for fees and expenses of counsel as contemplated by this paragraph, the
Indemnifying Person shall be liable for any settlement of any proceeding effected without its written consent if (i)&nbsp;such settlement is entered into more than 30 days after receipt by the Indemnifying Person of such request and (ii)&nbsp;the
Indemnifying Person shall not have reimbursed the Indemnified Person in accordance with such request prior to the date of such settlement. No Indemnifying Person shall, without the written consent of the Indemnified Person, effect any settlement of
any pending or threatened proceeding in respect of which any Indemnified Person is or could have been a party and indemnification could have been sought hereunder by such Indemnified Person, unless such settlement (x)&nbsp;includes an unconditional
release of such Indemnified Person, in form and substance reasonably satisfactory to such Indemnified Person, from all liability on claims that are the subject matter of such proceeding and (y)&nbsp;does not include any statement as to or any
admission of fault, culpability or a failure to act by or on behalf of any Indemnified Person. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) <I>Contribution.</I> If the
indemnification provided for in paragraphs (a)&nbsp;and (b) above is unavailable to an Indemnified Person or insufficient in respect of any losses, claims, damages or liabilities referred to therein, then each Indemnifying Person under such
paragraph, in lieu of indemnifying such Indemnified Person thereunder, shall contribute to the amount paid or payable by such Indemnified Person as a result of such losses, claims, damages or liabilities (i)&nbsp;in such proportion as is appropriate
to reflect the relative benefits received by the Company on the one hand and the Underwriters on the other from the offering of the Securities or (ii)&nbsp;if the allocation provided by clause (i)&nbsp;is not permitted by applicable law, in such
proportion as is appropriate to reflect not only the relative benefits referred to in clause (i)&nbsp;but also the relative fault of the Company on the one hand and the Underwriters on the other in connection with the statements or omissions that
resulted in such losses, claims, damages or liabilities, as well as any other relevant equitable considerations. The relative benefits received by the Company on the one hand and the Underwriters on the other shall be deemed to be in the same
respective proportions as the net proceeds (before deducting expenses) received by the Company from the sale of the Securities and the total underwriting discount received by the Underwriters in connection therewith, in each case as set forth in the
table on the cover of the Prospectus, bear to the aggregate offering price of the Securities. The relative fault of the Company on the one hand and the Underwriters on the other shall be determined by reference to, among other things, whether the
untrue or alleged untrue statement of a material fact or the omission or alleged omission to state a material fact relates to information supplied by the Company or by the Underwriters and the parties&#146; relative intent, knowledge, access to
information and opportunity to correct or prevent such statement or omission. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">21 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) <I>Limitation on Liability.</I> The Company and the Underwriters agree that it would not
be just and equitable if contribution pursuant to this Section&nbsp;7 were determined by <U>pro</U> <U>rata</U> allocation (even if the Underwriters were treated as one entity for such purpose) or by any other method of allocation that does not take
account of the equitable considerations referred to in paragraph (d)&nbsp;above. The amount paid or payable by an Indemnified Person as a result of the losses, claims, damages and liabilities referred to in paragraph (d)&nbsp;above shall be deemed
to include, subject to the limitations set forth above, any legal or other expenses incurred by such Indemnified Person in connection with any such action or claim. Notwithstanding the provisions of this Section&nbsp;7, in no event shall an
Underwriter be required to contribute any amount in excess of the amount by which the total underwriting discounts and commissions received by such Underwriter with respect to the offering of the Securities exceeds the amount of any damages that
such Underwriter has otherwise been required to pay by reason of such untrue or alleged untrue statement or omission or alleged omission. No person guilty of fraudulent misrepresentation (within the meaning of Section&nbsp;11(f) of the Securities
Act) shall be entitled to contribution from any person who was not guilty of such fraudulent misrepresentation. The Underwriters&#146; obligations to contribute pursuant to this Section&nbsp;7 are several in proportion to their respective purchase
obligations hereunder and not joint. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f) <I><FONT STYLE="white-space:nowrap">Non-Exclusive</FONT> Remedies.</I> The remedies provided for
in this Section&nbsp;7 are not exclusive and shall not limit any rights or remedies which may otherwise be available to any Indemnified Person at law or in equity. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8. <U>Effectiveness of Agreement</U>. This Agreement shall become effective upon the execution and delivery hereof by the parties hereto. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">9. <U>Termination</U>. This Agreement may be terminated in the absolute discretion of the Representatives, by notice to the Company, if after
the execution and delivery of this Agreement and prior to the Closing Date (i)&nbsp;trading generally shall have been suspended or materially limited on the New York Stock Exchange or the <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">over-the-counter</FONT></FONT> market; (ii)&nbsp;trading of any securities issued or guaranteed by the Company shall have been suspended on any exchange or in any <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">over-the-counter</FONT></FONT> market; (iii)&nbsp;a general moratorium on commercial banking activities shall have been declared by federal or New York State authorities; or (iv)&nbsp;there shall have occurred any outbreak
or escalation of hostilities or any change in financial markets or any calamity or crisis, either within or outside the United States, that, in the judgment of the Representatives, is material and adverse and makes it impracticable or inadvisable to
proceed with the offering, sale or delivery of the Securities on the terms and in the manner contemplated by this Agreement, the Time of Sale Information and the Prospectus. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">10. <U>[Reserved].</U> </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">22 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">11. <U>Defaulting Underwriter</U>. (a)&nbsp;If, on the Closing Date, any Underwriter
defaults on its obligation to purchase the Securities that it has agreed to purchase hereunder, the <FONT STYLE="white-space:nowrap">non-defaulting</FONT> Underwriters may in their discretion arrange for the purchase of such Securities by other
persons satisfactory to the Company on the terms contained in this Agreement. If, within 36 hours after any such default by any Underwriter, the <FONT STYLE="white-space:nowrap">non-defaulting</FONT> Underwriters do not arrange for the purchase of
such Securities, then the Company shall be entitled to a further period of 36 hours within which to procure other persons satisfactory to the <FONT STYLE="white-space:nowrap">non-defaulting</FONT> Underwriters to purchase such Securities on such
terms. If other persons become obligated or agree to purchase the Securities of a defaulting Underwriter, either the <FONT STYLE="white-space:nowrap">non-defaulting</FONT> Underwriters or the Company may postpone the Closing Date for up to five full
business days in order to effect any changes that in the opinion of counsel for the Company or counsel for the Underwriters may be necessary in the Registration Statement and the Prospectus or in any other document or arrangement, and the Company
agrees to promptly prepare any amendment or supplement to the Registration Statement and the Prospectus that effects any such changes. As used in this Agreement, the term &#147;Underwriter&#148; includes, for all purposes of this Agreement unless
the context otherwise requires, any person not listed in Schedule 1 hereto that, pursuant to this Section&nbsp;11, purchases Securities that a defaulting Underwriter agreed to, but failed to, purchase. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) If, after giving effect to any arrangements for the purchase of the Securities of a defaulting Underwriter or Underwriters by the <FONT
STYLE="white-space:nowrap">non-defaulting</FONT> Underwriters and the Company as provided in paragraph (a)&nbsp;above, the aggregate principal amount of such Securities that remains unpurchased does not exceed
<FONT STYLE="white-space:nowrap">one-eleventh</FONT> of the aggregate principal amount of all the Securities, then the Company shall have the right to require each <FONT STYLE="white-space:nowrap">non-defaulting</FONT> Underwriter to purchase the
principal amount of Securities that such Underwriter agreed to purchase hereunder plus such Underwriter&#146;s <U>pro</U> <U>rata</U> share (based on the principal amount of Securities that such Underwriter agreed to purchase hereunder) of the
Securities of such defaulting Underwriter or Underwriters for which such arrangements have not been made. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) If, after giving effect to
any arrangements for the purchase of the Securities of a defaulting Underwriter or Underwriters by the <FONT STYLE="white-space:nowrap">non-defaulting</FONT> Underwriters and the Company as provided in paragraph (a)&nbsp;above, the aggregate
principal amount of such Securities that remains unpurchased exceeds <FONT STYLE="white-space:nowrap">one-eleventh</FONT> of the aggregate principal amount of all the Securities, or if the Company shall not exercise the right described in paragraph
(b)&nbsp;above, then this Agreement shall terminate without liability on the part of the <FONT STYLE="white-space:nowrap">non-defaulting</FONT> Underwriters. Any termination of this Agreement pursuant to this Section&nbsp;11 shall be without
liability on the part of the Company, except that the Company will continue to be liable for the payment of expenses as set forth in Section&nbsp;12 hereof and except that the provisions of Section&nbsp;7 hereof shall not terminate and shall remain
in effect. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) Nothing contained herein shall relieve a defaulting Underwriter of any liability it may have to the Company or any <FONT
STYLE="white-space:nowrap">non-defaulting</FONT> Underwriter for damages caused by its default. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">23 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">12. <U>Payment of Expenses</U><I>.</I> (a)&nbsp;Whether or not the transactions contemplated
by this Agreement are consummated or this Agreement is terminated, the Company will pay or cause to be paid all costs and expenses incident to the performance of its obligations hereunder, including without limitation, (i)&nbsp;the costs incident to
the authorization, issuance, sale, preparation and delivery of the Securities and any taxes payable in that connection; (ii)&nbsp;the costs incident to the preparation, printing and filing under the Securities Act of the Registration Statement, the
Preliminary Prospectus, any Issuer Free Writing Prospectus, any Time of Sale Information and the Prospectus (including all exhibits, amendments and supplements thereto) and the distribution thereof; (iii)&nbsp;the costs of reproducing and
distributing each of the Transaction Documents; (iv)&nbsp;the fees and expenses of the Company&#146;s counsel and independent accountants; (v)&nbsp;the fees and expenses incurred in connection with the registration or qualification and determination
of eligibility for investment of the Securities under the laws of such jurisdictions as the Representatives may designate and the preparation, printing and distribution of a Blue Sky Memorandum (including the related fees and expenses of counsel for
the Underwriters); (vi) any fees charged by rating agencies for rating the Securities; (vii)&nbsp;the fees and expenses of the Trustee and any paying agent (including related fees and expenses of any counsel to such parties); (viii) all expenses and
application fees incurred in connection with any filing with, and clearance of the offering by, the Financial Industry Regulatory Authority, Inc.; and (ix)&nbsp;all expenses incurred by the Company in connection with any &#147;road show&#148;
presentation to potential investors. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) If (i)&nbsp;this Agreement is terminated pursuant to Section&nbsp;9, (ii) the Company for any
reason fails to tender the Securities for delivery to the Underwriters or (iii)&nbsp;the Underwriters decline to purchase the Securities for any reason permitted under this Agreement (other than, in the cases of clause (ii)&nbsp;or (iii) hereunder,
as a result of the matters described in Section&nbsp;9(iii) hereof), the Company agrees to reimburse the Underwriters for all documented <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> costs and expenses
(including the reasonable fees and expenses of their counsel) reasonably and actually incurred by the Underwriters in connection with this Agreement and the offering contemplated hereby. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">13. <U>Persons Entitled to Benefit of Agreement</U>. This Agreement shall inure to the benefit of and be binding upon the parties hereto and
their respective successors and the officers and directors and any controlling persons referred to herein, and the affiliates or selling agents of each Underwriter referred to in Section&nbsp;7 hereof. Nothing in this Agreement is intended or shall
be construed to give any other person any legal or equitable right, remedy or claim under or in respect of this Agreement or any provision contained herein. No purchaser of Securities from any Underwriter shall be deemed to be a successor merely by
reason of such purchase. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">14. <U>Survival</U>. The respective indemnities, rights of contribution, representations, warranties and
agreements of the Company and the Underwriters contained in this Agreement or made by or on behalf of the Company or the Underwriters pursuant to this Agreement or any certificate delivered pursuant hereto shall survive the delivery of and payment
for the Securities and shall remain in full force and effect, regardless of any termination of this Agreement or any investigation made by or on behalf of the Company or the Underwriters. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">24 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">15. <U>Certain Defined Terms</U>. For purposes of this Agreement, (a)&nbsp;except where
otherwise expressly provided, the term &#147;<B>affiliate</B>&#148; has the meaning set forth in Rule 405 under the Securities Act; (b)&nbsp;the term &#147;<B>business</B> <B>day</B>&#148; means any day other than a day on which banks are permitted
or required to be closed in New York City; (c)&nbsp;the term &#147;<B>subsidiary</B>&#148; has the meaning set forth in Rule 405 under the Securities Act, and the Company&#146;s current subsidiaries are as listed in Exhibit 21.01 to its Annual
Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> for the year ended December&nbsp;31, 2022; and (d)&nbsp;the term &#147;<B>significant</B> <B>subsidiary</B>&#148; has the meaning set forth in Rule
<FONT STYLE="white-space:nowrap">1-02</FONT> of Regulation <FONT STYLE="white-space:nowrap">S-X</FONT> under the Exchange Act. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">16.
<U>Compliance with USA Patriot Act</U>. In accordance with the requirements of the USA Patriot Act (Title III of Pub. L. <FONT STYLE="white-space:nowrap">107-56</FONT> (signed into law October&nbsp;26, 2001)), the Underwriters are required to
obtain, verify and record information that identifies their respective clients, including the Company, which information may include the name and address of their respective clients, as well as other information that will allow the Underwriters to
properly identify their respective clients. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">17. <U>Miscellaneous</U>. (a)<I>&nbsp;Authority of the Representatives.</I> Any action by the
Underwriters hereunder may be taken by the Representatives on behalf of the Underwriters, and any such action taken by the Representatives shall be binding upon the Underwriters. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) <I>Notices.</I> All notices and other communications hereunder shall be in writing and shall be deemed to have been duly given if mailed
or transmitted and confirmed by any standard form of telecommunication. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Notices to the Underwriters shall be given to the Representatives
c/o (1)&nbsp;BofA Securities, Inc., 114 West 47th Street, <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">NY8-114-07-01,</FONT></FONT></FONT> New York, New York 10036, Attention: High Grade Debt
Capital Markets Transaction Management/Legal, Facsimile: <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">212-901-7881;</FONT></FONT> (2) Citigroup Global Markets Inc., 388 Greenwich Street, New York, New York 10013, Attention:
General Counsel; Facsimile: <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">646-291-1469;</FONT></FONT> (3) J.P. Morgan Securities LLC, 383 Madison Avenue, New York, New York 10179, Attention: Investment Grade Syndicate Desk,
Facsimile: <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">212-834-6081;</FONT></FONT> (4) Mizuho Securities USA LLC, 1271 Avenue of the Americas, New York, New York 10020, Attention: Debt Capital Markets, email:
legalnotices@mizuhogroup.com; and (5)&nbsp;Wells Fargo Securities, LLC, 550 South Tryon Street, 5th Floor, Charlotte, North Carolina 28202, Attention: Transaction Management, email: tmgcapitalmarkets@wellsfargo.com. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Notices to the Company shall be given to it at Eastman Chemical Company, 200 S. Wilcox Drive, Kingsport, Tennessee 37662, Attention:
Treasurer, Facsimile: <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">423-224-0314,</FONT></FONT> email: treasury.ops@eastman.com. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) <I>Governing Law.</I> This Agreement and any claim, controversy or dispute arising under or related to this Agreement shall be governed by
and construed in accordance with the laws of the State of New York. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) <I>Waiver of Jury Trial.</I> Each of the parties hereto hereby
waives any right to trial by jury in any suit or proceeding arising out of or relating to this Agreement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">25 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) <I>Counterparts.</I> This Agreement may be signed in counterparts (which may include
counterparts delivered by any standard form of telecommunication), each of which shall be an original and all of which together shall constitute one and the same instrument. Counterparts may be delivered via facsimile, electronic mail (including any
electronic signature covered by the U.S. federal ESIGN Act of 2000, Uniform Electronic Transactions Act, the Electronic Signatures and Records Act or other applicable law, e.g., www.docusign.com) or other transmission method and any counterpart so
delivered shall be deemed to have been duly and validly delivered and be valid and effective for all purposes. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f) <I>Amendments or
Waivers.</I> No amendment or waiver of any provision of this Agreement, nor any consent or approval to any departure therefrom, shall in any event be effective unless the same shall be in writing and signed by the parties hereto. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(g) <I>Headings.</I> The headings herein are included for convenience of reference only and are not intended to be part of, or to affect the
meaning or interpretation of, this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(h) <I>Recognition of the U.S. Special Resolution Regimes. </I>In the event that any
Underwriter that is a Covered Entity becomes subject to a proceeding under a U.S. Special Resolution Regime, the transfer from such Underwriter of this Agreement, and any interest and obligation in or under this Agreement, will be effective to the
same extent as the transfer would be effective under the U.S. Special Resolution Regime. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In the event that any Underwriter that is a
Covered Entity or a BHC Act Affiliate of such Underwriter becomes subject to a proceeding under a U.S. Special Resolution Regime, Default Rights under this Agreement that may be exercised against such Underwriter are permitted to be exercised to no
greater extent than such Default Rights could be exercised under the U.S. Special Resolution Regime. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As used in this Section: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1) &#147;<B>BHC Act Affiliate</B>&#148; has the meaning assigned to the term &#147;affiliate&#148; in, and shall be interpreted in accordance
with, 12 U.S.C. &#167; 1841(k). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(2) &#147;<B>Covered</B> <B>Entity</B>&#148; means any of the following: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) a &#147;<B>covered</B> <B>entity</B>&#148; as that term is defined in, and interpreted in accordance with, 12 C.F.R. &#167; 252.82(b);
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) a &#147;<B>covered</B> <B>bank</B>&#148; as that term is defined in, and interpreted in accordance with, 12 C.F.R. &#167; 47.3(b);
or </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iii) a &#147;<B>covered</B> <B>FSI</B>&#148; as that term is defined in, and interpreted in accordance with, 12 C.F.R. &#167;
382.2(b). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(3) &#147;<B>Default</B> <B>Right</B>&#148; has the meaning assigned to that term in, and shall be interpreted in accordance
with, 12 C.F.R. &#167;&#167; 252.81, 47.2 or 382.1, as applicable. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">26 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(4) &#147;<B>U.S. Special Resolution Regime</B>&#148; means each of (i)&nbsp;the Federal
Deposit Insurance Act and the regulations promulgated thereunder and (ii)&nbsp;Title II of the Dodd-Frank Wall Street Reform and Consumer Protection Act and the regulations promulgated thereunder. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>[Remainder of page is blank; signature pages as follows] </I></P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">27 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If the foregoing is in accordance with your understanding, please indicate your acceptance
of this Agreement by signing in the space provided below. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Very truly yours,</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">EASTMAN CHEMICAL COMPANY</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Kevin H. Wang</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name: Kevin H. Wang</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title: Vice President and Treasurer</TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[<I>Signature Page to Underwriting Agreement</I>] </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Accepted: February&nbsp;15, 2024 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">BOFA SECURITIES, INC. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>For itself and on behalf of the
several Underwriters listed in Schedule 1 hereto. </I></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Kevin Wehler</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name: Kevin Wehler</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title: Managing Director</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>[SIGNATURE PAGE &#150; EMN UNDERWRITING AGREEMENT] </I></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Accepted: February&nbsp;15, 2024 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">CITIGROUP GLOBAL MARKETS INC. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>For itself and on behalf of
the several Underwriters listed in Schedule 1 hereto. </I></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Adam D. Bordner</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name: Adam D. Bordner</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title: Managing Director</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>[SIGNATURE PAGE &#150; EMN UNDERWRITING AGREEMENT] </I></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Accepted: February&nbsp;15, 2024 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">J.P. MORGAN SECURITIES LLC </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>For itself and on behalf of the
several Underwriters listed in Schedule 1 hereto. </I></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Som Bhattacharyya</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name: Som Bhattacharyya</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title: Executive Director</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>[SIGNATURE PAGE &#150; EMN UNDERWRITING AGREEMENT] </I></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Accepted: February&nbsp;15, 2024 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">MIZUHO SECURITIES USA LLC </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>For itself and on behalf of the
several Underwriters listed in Schedule 1 hereto. </I></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Joseph Santaniello</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name: Joseph Santaniello</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title: Director</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>[SIGNATURE PAGE &#150; EMN UNDERWRITING AGREEMENT] </I></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Accepted: February&nbsp;15, 2024 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">WELLS FARGO SECURITIES, LLC </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>For itself and on behalf of the
several Underwriters listed in Schedule 1 hereto. </I></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Carolyn Hurley</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name: Carolyn Hurley</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title: Managing Director</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>[SIGNATURE PAGE &#150; EMN UNDERWRITING AGREEMENT] </I></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Schedule 1 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="83%"></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Underwriters</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Aggregate&nbsp;Principal<BR>Amount&nbsp;of&nbsp;the&nbsp;Securities<BR>to be Purchased</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">BofA Securities, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">97,500,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Citigroup Global Markets Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">97,500,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">J.P. Morgan Securities LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">97,500,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Mizuho Securities USA LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">97,500,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Wells Fargo Securities, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">97,500,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Barclays Capital Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">43,125,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">BNP Paribas Securities Corp.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">43,125,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Morgan Stanley&nbsp;&amp; Co. LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">43,125,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Truist Securities, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">43,125,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">PNC Capital Markets LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">15,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">RBC Capital Markets, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">15,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Scotia Capital (USA) Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">15,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Siebert Williams Shank&nbsp;&amp; Co., LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">15,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SMBC Nikko Securities America, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">15,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">UniCredit Capital Markets LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">15,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Total:</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">750,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Annex <FONT STYLE="white-space:nowrap">A-1</FONT> </B></P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Form of Opinion and Negative Assurance Letter of Wilmer Cutler Pickering Hale and Dorr LLP </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[See attached.] </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Annex <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">A-1-1</FONT></FONT> </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Annex <FONT STYLE="white-space:nowrap">A-2</FONT> </B></P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Opinion of Company Legal Officer </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[See attached.] </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Annex B </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Time of Sale Information </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Term Sheet
dated February&nbsp;15, 2024 in the form attached as Annex C hereto </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Annex B-1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Annex C </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Filed Pursuant to Rule 433 of the Securities Act of 1933 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Registration Statement No.&nbsp;333- 257008 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>February&nbsp;15, 2024 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>Pricing Term Sheet </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Eastman Chemical Company </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>$750,000,000 5.625% Notes due 2034 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="22%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="77%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Issuer:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Eastman Chemical Company (the &#147;Company&#148;)</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Expected Ratings<SUP STYLE="font-size:75%; vertical-align:top">(1)</SUP>:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><I>[**Internationally Omitted**]</I></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Trade Date:</P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Settlement Date:</P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Security Type:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">February&nbsp;15, 2024</P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">February&nbsp;20, 2024 (T+2)</P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Senior Unsecured Notes</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Offering Format:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><FONT STYLE="white-space:nowrap">SEC-Registered</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Principal Amount:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">$750,000,000</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Interest Payment Dates:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Semi-annually on February&nbsp;20 and August&nbsp;20 of each year, beginning August&nbsp;20, 2024</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Maturity Date:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">February&nbsp;20, 2034</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Coupon:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">5.625%</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Price to Public:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">99.811% of the principal amount, plus accrued interest, if any, from February&nbsp;20, 2024</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Yield to Maturity:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">5.650%</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Benchmark Treasury:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">4.000% due February&nbsp;15, 2034</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Benchmark Treasury Price and Yield:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="white-space:nowrap">98-04+;</FONT> 4.230%</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Spread to Benchmark Treasury:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">+142 bps</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Make-whole Call:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Prior to November&nbsp;20, 2033 at T + 25 bps</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Par Call:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">On or after November&nbsp;20, 2033</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Change of Control:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Upon the occurrence of a change of control triggering event, the Company will be required to make an offer to repurchase all or a portion of the notes at a price equal to 101% of principal, plus accrued and unpaid interest to, but
excluding, the repurchase date.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Use of Proceeds:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">The Company intends to use the net proceeds from this offering for general corporate purposes, which may include working capital, capital expenditures, the repayment of other indebtedness outstanding from time to time, and other
matters in connection with implementation of our strategic initiatives.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">CUSIP / ISIN:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">277432 AY6 / US277432AY69</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Denominations:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">$2,000 and integral multiples of $1,000 in excess thereof</TD></TR>
</TABLE> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Annex C </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="22%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="77%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Day Count Convention:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">30 / 360</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Clearing and Settlement:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">DTC</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Joint Book-Running Managers:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">BofA Securities, Inc.</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Citigroup Global Markets Inc.</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">J.P. Morgan Securities LLC</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Mizuho Securities USA LLC</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Wells Fargo Securities, LLC</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Barclays Capital Inc.</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">BNP Paribas Securities Corp.</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Morgan Stanley&nbsp;&amp; Co. LLC</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Truist Securities, Inc.</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">Co-Managers:</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">PNC Capital Markets LLC</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">RBC Capital Markets, LLC</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Scotia Capital (USA) Inc.</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Siebert Williams Shank&nbsp;&amp; Co., LLC</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SMBC Nikko Securities America, Inc.</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">UniCredit Capital Markets LLC</P></TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>(1)</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>A credit rating of a security is not a recommendation to buy, sell or hold securities and may be subject to
review, revision, suspension, reduction or withdrawal at any time by the assigning rating agency. </B></P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>The issuer has filed a
registration statement (including a base prospectus) and a preliminary prospectus supplement with the SEC for the offering to which this communication relates. The issuer files annual, quarterly, and current reports, proxy statements and other
information with the SEC. Before you invest, you should read the preliminary prospectus supplement for this offering, the issuer&#146;s prospectus in the registration statement and any other documents the issuer has filed with the SEC for more
complete information about the issuer and this offering. We urge you to read these documents and any other relevant documents when they become available because they contain and will contain important information about the issuer and this offering.
You may get these documents for free by searching the SEC online database (EDGAR) on the SEC&#146;s website at http://www.sec.gov. Alternatively, any underwriter or any dealer participating in this offering will arrange to send you, when available,
the prospectus supplement and the prospectus if you request it by calling BofA Securities, Inc. at <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">1-800-294-1322,</FONT></FONT></FONT> Citigroup
Global Markets Inc. at <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">1-800-831-9146,</FONT></FONT></FONT> J.P. Morgan Securities LLC at <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">1-212-834-4533,</FONT></FONT></FONT> Mizuho Securities USA LLC at
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">1-866-271-7403</FONT></FONT></FONT> or Wells Fargo Securities, LLC at <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">1-800-645-3751.</FONT></FONT></FONT> </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>This pricing term sheet supplements the preliminary prospectus supplement issued
by Eastman Chemical Company on February&nbsp;15, 2024 relating to its prospectus dated June&nbsp;11, 2021 (such prospectus, as supplemented by such preliminary prospectus supplement, the &#147;Preliminary Prospectus&#148;). The information in this
pricing term sheet supersedes the information in the Preliminary Prospectus to the extent inconsistent with the information in the Preliminary Prospectus. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>ANY DISCLAIMER OR OTHER NOTICE THAT MAY APPEAR BELOW IS NOT APPLICABLE TO THIS COMMUNICATION AND SHOULD BE DISREGARDED. SUCH DISCLAIMER OR NOTICE WAS
AUTOMATICALLY GENERATED AS A RESULT OF THIS COMMUNICATION BEING SENT BY BLOOMBERG OR ANOTHER EMAIL SYSTEM. </I></B></P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.2
<SEQUENCE>3
<FILENAME>d681849dex42.htm
<DESCRIPTION>EX-4.2
<TEXT>
<HTML><HEAD>
<TITLE>EX-4.2</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 4.2 </B></P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>[FACE OF NOTE] </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">THIS NOTE IS A GLOBAL
NOTE WITHIN THE MEANING OF THE INDENTURE HEREINAFTER REFERRED TO AND IS REGISTERED IN THE NAME OF THE DEPOSITORY TRUST COMPANY (&#147;<B><I>DTC</I></B>&#148;), OR A NOMINEE OF THE DEPOSITORY TRUST COMPANY. THIS NOTE IS EXCHANGEABLE FOR NOTES
REGISTERED IN THE NAME OF A PERSON OTHER THAN DTC OR ITS NOMINEE ONLY IN THE LIMITED CIRCUMSTANCES DESCRIBED IN THE INDENTURE AND MAY NOT BE TRANSFERRED EXCEPT AS A WHOLE BY DTC TO A NOMINEE OF DTC OR BY A NOMINEE OF DTC TO DTC OR ANOTHER NOMINEE OF
DTC. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">UNLESS THIS CERTIFICATE IS PRESENTED BY AN AUTHORIZED REPRESENTATIVE OF DTC TO THE COMPANY OR ITS AGENT FOR REGISTRATION OF TRANSFER, EXCHANGE, OR
PAYMENT, AND ANY CERTIFICATE ISSUED IS REGISTERED IN THE NAME OF CEDE&nbsp;&amp; CO. OR IN SUCH OTHER NAME AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC (AND ANY PAYMENT IS MADE TO CEDE&nbsp;&amp; CO. OR TO SUCH OTHER ENTITY AS IS REQUESTED
BY AN AUTHORIZED REPRESENTATIVE OF DTC), ANY TRANSFER, PLEDGE, OR OTHER USE HEREOF FOR VALUE OR OTHERWISE BY OR TO ANY PERSON IS WRONGFUL INASMUCH AS THE REGISTERED OWNER HEREOF, CEDE&nbsp;&amp; CO., HAS AN INTEREST HEREIN. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Eastman Chemical Company </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="37%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="62%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">No. A.-</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">5.625% NOTE DUE 2034</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">CUSIP No.&nbsp;277432 AY6</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">$&#8195;&#8195;</TD></TR>
</TABLE> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ISIN No. US277432AY69 </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Eastman Chemical Company, a corporation duly organized and existing under the laws of the State of Delaware (the
&#147;<B><I>Company</I></B>&#148;), for value received, hereby promises to pay CEDE&nbsp;&amp; CO., or its registered assigns, the principal sum of $&#8195;(&#8195;&#8195;&#8195;&#8195;Million United States dollars) or such other amounts that appear
in the schedule attached hereto on February&nbsp;20, 2034 (the &#147;<B><I>Maturity Date</I></B>&#148;), in such coin or currency of the United States of America as at the time of payment shall be legal tender for the payment of public and private
debts, and to pay semi-annually in arrears on February&nbsp;20 and August&nbsp;20 of each year (each, an &#147;<B><I>Interest Payment Date</I></B>&#148;), commencing August&nbsp;20, 2024, and on the Maturity Date (or on any redemption or repayment
date) the amount of interest on said principal sum, in like coin or currency, at the rate per annum specified in the title of this Note, from and including February&nbsp;20, 2024 or from but excluding the most recent Interest Payment Date to which
interest has been paid or duly provided for until said principal sum has been paid or duly provided for. Interest shall be computed on the basis of a <FONT STYLE="white-space:nowrap">360-day</FONT> year consisting of twelve <FONT
STYLE="white-space:nowrap">30-day</FONT> months. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The interest payable on any Interest Payment Date which is punctually paid or duly
provided for on such Interest Payment Date will be paid to the Person in whose name this Note (or one or more predecessor Notes) is registered at the close of business on February&nbsp;5 or August&nbsp;5 (in each case, whether or not a Business
Day), as the case may be (each, a &#147;<B><I>Regular Record Date</I></B>&#148;), immediately preceding such Interest Payment Date. Interest payable on this Note which is not punctually paid or duly provided for on any Interest Payment Date therefor
shall forthwith cease to be payable to the Person in whose name this Note is registered at the close of business on the Regular Record Date immediately preceding such Interest Payment Date, and such interest may either (i)&nbsp;be paid to the Person
in whose name this Note is registered at the close of business on a special record date to be established for such payment by the Trustee or (ii)&nbsp;be paid in any other lawful manner not inconsistent with the requirements of any securities
exchange on which the Notes may be listed, all as more fully provided in the Indenture referred to on the reverse hereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Payment of the
principal, any premium and the interest due on the Maturity Date (or on any redemption or repayment date) of this Note will be made in immediately available funds upon surrender of this Note at the office or agency of the Paying Agent, as defined on
the reverse hereof, maintained for that purpose in the Borough of Manhattan, The City of New York, or at such other paying agency as the Company may determine. At the option of the Company, interest on the Notes may be paid by check mailed to the
address of the Person entitled thereto as such address shall appear in the register of Holders of the Notes. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Reference is made to the
further provisions of this Note set forth on the reverse hereof. Such further provisions shall for all purposes have the same effect as though fully set forth at this place. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This Note shall not be valid or become obligatory for any purpose until the certificate of
authentication hereon shall have been signed by the Trustee under the Indenture referred to on the reverse hereof. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">IN WITNESS WHEREOF, the Company has caused this Note to be signed manually or by facsimile
by its duly authorized officer. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dated: February&nbsp;20, 2024 </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Eastman Chemical Company</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name: Kevin Wang</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title: Vice President and Treasurer</TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[<I>Signature Page to 5.625% Note Due 2034</I>] </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This is one of the Notes of the series designated therein described in the within- mentioned
Indenture. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dated: February&nbsp;20, 2024 </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="45%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="46%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">Computershare Trust Company, National Association,</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">as Trustee</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">Authorized Signatory</TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[<I>Signature Page to 5.625% Note Due 2034</I>] </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>[REVERSE OF NOTE] </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1. INDENTURE. (a)&nbsp;This Note is one of a duly authorized issue of senior debt securities of the Company (hereinafter called the
&#147;<B><I>Notes</I></B>&#148;), all issued or to be issued under and pursuant to the Indenture, dated as of June&nbsp;5, 2012 (the &#147;<B><I>Indenture</I></B>&#148;), between the Company and Computershare Trust Company, National Association (as
successor to Wells Fargo Bank, National Association), as Trustee (the &#147;<B><I>Trustee</I></B>,&#148; which term includes any successor trustee under the Indenture), and reference is hereby made to the Indenture for a description of the rights,
limitations of rights, obligations, duties and immunities thereunder of the Company, the Trustee and the Holders of the Notes, and the terms upon which the Notes are, and are to be, authenticated and delivered. The Company has appointed the Trustee
as the paying agent (the &#147;<B><I>Paying Agent</I></B>,&#148; which term includes any additional or successor Paying Agent appointed by the Company) with respect to the Notes. To the extent not inconsistent herewith, the terms of the Indenture
are hereby incorporated by reference herein. This Note is one of the series designated on the face hereof initially limited in aggregate principal amount to $750,000,000; provided that the Company may from time to time, without notice to or the
consent of the Holders of the Notes, create and issue additional Notes (the &#147;<B><I>Additional Notes</I></B>&#148;) having the same terms and ranking equally and ratably with the existing Notes, in all respects and with the same CUSIP number as
the existing Notes, or in all respects except for any differences in the issue price and the payment of interest accruing prior to the issue date of the Additional Notes or for the first payment of interest following the issue date of such
Additional Notes. Any Additional Notes will be consolidated and form a single series with the existing Notes and shall have the same terms as to status, redemption and otherwise as such Notes. Any Additional Notes may be issued pursuant to
authorization provided by a resolution of the Board of Directors of the Company, a supplement to the Indenture, or under an Officers&#146; Certificate pursuant to the Indenture. No Additional Notes may be issued if an Event of Default has occurred
and is continuing with respect to the existing Notes. If such Additional Notes are not fungible for purposes of U.S. federal income tax purposes, such Additional Notes shall have a different CUSIP number. (b)&nbsp;All capitalized terms used in this
Note which are defined in the Indenture and not otherwise defined herein shall have the meanings assigned to them in the Indenture. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.
AMENDMENTS AND WAIVERS. The Indenture permits, with certain exceptions as therein provided, the amendment thereof and the modification of the rights and obligations of the Company and the rights of the Holders of the Notes of any series and the
Trustee with the consent of the Holders of a majority in aggregate principal amount of all of the Notes of each applicable series then Outstanding affected by such amendment or modification (treated as a single class). The Indenture also contains
provisions permitting the Holders of a majority in aggregate principal amount of all of the Notes of each applicable series then Outstanding affected thereby (treated as a single class) to waive compliance by the Company with certain provisions of
the Indenture and certain past defaults under the Indenture and their consequences. For the avoidance of doubt, with respect to any series of Notes, the consent or waiver, as the case may be, of Holders of Notes of such series required or permitted
under the Indenture, as the case may be, if the Company so determines, may also be obtained from the Holders of a majority in principal amount of the Notes of that series. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3. OBLIGATION TO PAY PRINCIPAL, PREMIUM, IF ANY, AND INTEREST. No reference herein to the
Indenture and no provision of this Note or of the Indenture shall alter or impair the obligation of the Company or any other obligor on the Notes, which is absolute and unconditional, to pay the principal of, premium, if any, and interest on this
Note in the manner, at the respective times, at the rate, and in the coin or currency herein prescribed. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4. OPTIONAL REDEMPTION. Prior to
November&nbsp;20, 2033 (three months prior to this Note&#146;s maturity date (the &#147;<B><I>Par Call Date</I></B>&#148;)), the Company may redeem this Note at its option, in whole or in part, at any time and from time to time, at a redemption
price (expressed as a percentage of the principal amount and rounded to three decimal places) equal to the greater of: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1)(a) the sum of
the present values of the remaining scheduled payments of principal and interest thereon discounted to the redemption date (assuming this Note matured on the Par Call Date) on a semi-annual basis (assuming a
<FONT STYLE="white-space:nowrap">360-day</FONT> year consisting of twelve <FONT STYLE="white-space:nowrap">30-day</FONT> months) at the Treasury Rate plus 25 basis points less (b)&nbsp;interest accrued to the date of redemption, and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(2) 100% of the principal amount of this Note to be redeemed, </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">plus, in either case, accrued and unpaid interest thereon to the redemption date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On or after the Par Call Date, the Company may redeem this Note, in whole or in part, at any time and from time to time, at a redemption price
equal to 100% of the principal amount of this Note being redeemed plus accrued and unpaid interest thereon to the redemption date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For
purposes of Section&nbsp;4 of this Note, the following definitions are applicable: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Treasury Rate</I></B>&#148; means, with
respect to any redemption date, the yield determined by the Company in accordance with the following two paragraphs. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Treasury Rate
shall be determined by the Company after 4:15 p.m., New York City time (or after such time as yields on U.S. government securities are posted daily by the Board of Governors of the Federal Reserve System), on the third business day preceding the
redemption date based upon the yield or yields for the most recent day that appear after such time on such day in the most recent statistical release published by the Board of Governors of the Federal Reserve System designated as &#147;Selected
Interest Rates (Daily) - H.15&#148; (or any successor designation or publication) (&#147;<B><I>H.15</I></B>&#148;) under the caption &#147;U.S. government securities&#150;Treasury constant maturities&#150;Nominal&#148; (or any successor caption or
heading) (&#147;<B><I>H.15 TCM</I></B>&#148;). In determining the Treasury Rate, the Company shall select, as applicable: (1)&nbsp;the yield for the Treasury constant maturity on H.15 exactly equal to the period from the redemption date to the Par
Call Date (the &#147;<B><I>Remaining Life</I></B>&#148;); or (2)&nbsp;if there is no such Treasury constant maturity on H.15 exactly equal to the Remaining Life, the two yields &#150; one yield corresponding to the Treasury constant maturity on H.15
immediately shorter than and one yield corresponding to the Treasury constant maturity on H.15 immediately longer than the Remaining Life &#150; and shall interpolate to the Par Call Date on a straight-line basis (using the actual number of days)
using such yields and rounding the result to three decimal places; or (3)&nbsp;if there is no such Treasury constant maturity on H.15 shorter than or longer than the Remaining Life, the yield for the single Treasury constant maturity on H.15 closest
to the Remaining Life. For purposes of this paragraph, the applicable Treasury constant maturity or maturities on H.15 shall be deemed to have a maturity date equal to the relevant number of months or years, as applicable, of such Treasury constant
maturity from the redemption date. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If on the third business day preceding the redemption date H.15 TCM is no longer published,
the Company shall calculate the Treasury Rate based on the rate per annum equal to the semi-annual equivalent yield to maturity at 11:00 a.m., New York City time, on the second business day preceding such redemption date of the United States
Treasury security maturing on, or with a maturity that is closest to, the Par Call Date, as applicable. If there is no United States Treasury security maturing on the Par Call Date but there are two or more United States Treasury securities with a
maturity date equally distant from the Par Call Date, one with a maturity date preceding the Par Call Date and one with a maturity date following the Par Call Date, the Company shall select the United States Treasury security with a maturity date
preceding the Par Call Date. If there are two or more United States Treasury securities maturing on the Par Call Date or two or more United States Treasury securities meeting the criteria of the preceding sentence, the Company shall select from
among these two or more United States Treasury securities the United States Treasury security that is trading closest to par based upon the average of the bid and asked prices for such United States Treasury securities at 11:00 a.m., New York City
time. In determining the Treasury Rate in accordance with the terms of this paragraph, the semi-annual yield to maturity of the applicable United States Treasury security shall be based upon the average of the bid and asked prices (expressed as a
percentage of principal amount) at 11:00 a.m., New York City time, of such United States Treasury security, and rounded to three decimal places. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company&#146;s actions and determinations in determining the redemption price shall be conclusive and binding for all purposes, absent
manifest error. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Notice of any redemption will be mailed or electronically delivered (or otherwise transmitted in accordance with
DTC&#146;s (or any successor depositary&#146;s) procedures) at least 10 days but not more than 60 days before the redemption date to each holder of Notes to be redeemed. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Notice of any redemption of Notes may, at the Company&#146;s discretion, be given subject to one or more conditions precedent, including, but
not limited to, completion of a corporate transaction that is pending (such as an equity or equity-linked offering, an incurrence of indebtedness or an acquisition or other strategic transaction involving a change of control in the Company or
another entity). If such redemption is so subject to satisfaction of one or more conditions precedent, such notice shall describe each such condition, and such notice may be rescinded in the event that any or all such conditions shall not have been
satisfied or otherwise waived on or prior to the Business Day immediately preceding the relevant redemption date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company shall
notify holders of any such rescission as soon as practicable after the Company determines that such conditions precedent will not be able to be satisfied or the Company is not able or willing to waive such conditions precedent, in each case subject
to policies and procedures of DTC (or any successor depositary). In any event, the Company shall provide written notice to the Trustee prior to the close of business on the Business Day prior to the relevant redemption date if any such redemption
has been rescinded or delayed, and upon receipt of such notice the Trustee, at the expense of the Company, shall provide such notice to each holder of the Notes in the same manner in which the notice of redemption was given. Once notice of
redemption is mailed or sent, subject to the satisfaction of any conditions precedent provided in the notice of redemption, the Notes called for redemption will become due and payable on the redemption date and at the applicable redemption price.
</P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In the case of a partial redemption, selection of the Notes for redemption will be made pro
rata, by lot or by such other method as the Trustee in its sole discretion deems appropriate and fair. No Notes of a principal amount of $2,000 or less will be redeemed in part. If any Note is to be redeemed in part only, the notice of redemption
that relates to the Note will state the portion of the principal amount of the Note to be redeemed and the CUSIP number of the Note to be redeemed. A new Note in a principal amount equal to the unredeemed portion of the Note will be issued in the
name of the holder of the Note upon surrender for cancellation of the original Note. For so long as the Notes are held by DTC (or another depositary), the redemption of this Note shall be done in accordance with the policies and procedures of the
depositary. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Unless the Company defaults in payment of the redemption price, on and after the redemption date, interest will cease to
accrue on this Note or the portion of this Note called for redemption. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5. RESTRICTIONS ON SECURED DEBT. The Company covenants and agrees
for the benefit of the Holder of this Note that for so long as this Note is outstanding, the Company will not, and the Company will not permit any Restricted Subsidiary to, incur, issue, assume or guarantee any notes, bonds, debentures or other
similar evidences of indebtedness for money borrowed (&#147;<B><I>Debt</I></B>&#148;), secured by pledge of, or mortgage or lien on, any Principal Property (as defined below) of the Company or any Restricted Subsidiary, or any shares of stock of or
Debt of any Restricted Subsidiary (such pledges, mortgages and liens being called &#147;<B><I>Mortgage</I></B>&#148; or &#147;<B><I>Mortgages</I></B>&#148; and such debt secured by such Mortgages being called &#147;<B><I>Secured Debt</I></B>&#148;),
without effectively providing that this Note (together with, if the Company shall so determine, any other indebtedness of the Company or such Restricted Subsidiary then existing or thereafter created which is not subordinate to this Note) shall be
secured equally and ratably with (or prior to) such Secured Debt, so long as such Secured Debt shall be so secured, unless after giving effect thereto, the aggregate amount of all such Secured Debt plus all Attributable Debt of the Company and the
Company&#146;s Restricted Subsidiaries in respect of any Sale and Leaseback Transaction (as defined below) would not exceed 15% of Consolidated Net Tangible Assets calculated as of the date of the creation or incurrence of such Secured Debt;
provided, however, that this restriction shall not apply to, and there shall be excluded from Secured Debt in any computation under such restriction, indebtedness secured by: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Mortgages on such property or shares of stock or Debt existing as of February&nbsp;20, 2024;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Mortgages securing only notes issued under the Indenture; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Mortgages on such property or shares of stock of or Debt of, any Person, which Mortgages are existing at the
time (i)&nbsp;such Person became a Restricted Subsidiary, (ii)&nbsp;such Person is merged into or consolidated with the Company or any Subsidiary or (iii)&nbsp;the Company or a Subsidiary merges into or consolidates with such Person (in a
transaction in which such Person becomes a Restricted Subsidiary), which Mortgage was not incurred in anticipation of such transaction and was outstanding prior to such transaction; </P></TD></TR></TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(d)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Mortgages in favor of the Company or any Restricted Subsidiary; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(e)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Mortgages in favor of any governmental body to secure progress, advance or other payments pursuant to any
contract or provision of any statute; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(f)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Mortgages on such property or shares of stock or Debt existing at the time of acquisition thereof (including
acquisition through merger or consolidation); </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(g)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Mortgages on such property or shares of stock or Debt to secure the payment of all or any part of the purchase
price or construction cost thereof or to secure any Debt incurred prior to, at the time of, or within 180 days after, the acquisition of such property or shares or Debt, the completion of any construction or the commencement of full operation, for
the purpose of financing all or any part of the purchase price or construction cost thereof; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(h)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Mortgages incurred in connection with a Sale and Leaseback Transaction satisfying the provisions under
Section&nbsp;6 of this Note; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Mortgages on receivables, leases, other financial assets, and any assets related thereto, incurred in
connection with any transaction or series of transactions entered into by the Company or any of its Subsidiaries in order to monetize or otherwise finance a pool (which may be fixed or revolving) of receivables, leases or other financial assets
(including, without limitation, financing contracts) or other transactions evidenced by receivables purchase agreements, including, without limitation, factoring agreements and other similar agreements pursuant to which receivables, leases, other
financial assets, and any assets related thereto, are sold at a discount (in each case whether now existing or arising in the future) and which may include a grant of a security interest in any such receivables, leases, other financial assets
(whether now existing or arising in the future) of the Company or any of its Subsidiaries, and any assets related thereto, including all collateral securing such receivables, leases, or other financial assets, all contracts and all guarantees or
other obligations in respect thereof, proceeds thereof and other assets that are customarily transferred, or in respect of which security interests are customarily granted, in connection with asset securitization transactions involving receivables,
leases, or other financial assets or other transactions evidenced by receivables purchase agreements, including, without limitation, factoring agreements and other similar agreements pursuant to which receivables are sold at a discount; and
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(j)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">any extension, renewal or replacement (or successive extensions, renewals or replacements), as a whole or in
part, of any Mortgage referred to in clauses (a)&nbsp;through (i); provided that such extension, renewal or replacement Mortgage shall be limited to all or a part of the same such property or shares of stock or Debt that secured the Mortgage
extended, renewed or replaced (plus improvements on such property). </P></TD></TR></TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6. LIMITATIONS ON SALE LEASEBACK TRANSACTIONS. The Company will not, and the Company will
not permit any Restricted Subsidiary to, enter into any arrangement with any bank, insurance company or other lender or investor (not including the Company or any Restricted Subsidiary) or to which any such lender or investor is a party, providing
for the leasing by the Company or a Restricted Subsidiary for a period, including renewals, in excess of three years of any Principal Property the ownership of which has been or is to be sold or transferred, more than 180 days after the completion
of construction and commencement of full operation thereof, by the Company or such Restricted Subsidiary to such lender or investor or to any Person to whom funds have been or are to be advanced by such lender or investor on the security of such
Principal Property (referred to as a &#147;<B><I>Sale and Leaseback Transaction</I></B>&#148;) unless either: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the Company or such Restricted Subsidiary could create Secured Debt pursuant to the provisions of
Section&nbsp;5 of this Note on the Principal Property to be leased in an amount equal to the Attributable Debt with respect to such Sale and Leaseback Transaction without equally and ratably securing this Note; or </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">(i) the net proceeds of the sale or transfer of the Principal Property leased pursuant to such Sale and
Leaseback Transaction is at least equal to the fair market value of such Principal Property and (ii)&nbsp;within 180 days after such sale or transfer shall have been made by the Company or by a Restricted Subsidiary, the Company applies an amount
not less than the greater of (1)&nbsp;the net proceeds of the sale of the Principal Property leased pursuant to such arrangement or (2)&nbsp;the fair market value of the Principal Property so leased at the time of entering into such arrangement (as
evidenced by an Officers&#146; Certificate) to the retirement of Funded Debt of the Company; provided that the amount to be applied to the retirement of Funded Debt of the Company shall be reduced by (x)&nbsp;the principal amount of notes issued
under the Indenture delivered within 180 days after such sale to the Trustee for retirement and cancellation, and (y)&nbsp;the principal amount of Funded Debt other than notes issued under the Indenture voluntarily retired by the Company within 180
days after such sale. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">No retirement referred to in clause (b)&nbsp;of Section&nbsp;6 of this Note may be effected by
payment. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B><I>Principal Property</I></B>&#148; means any single parcel of real estate, any single manufacturing plant or any
single warehouse owned or leased in connection with a Sale and Leaseback Transaction by the Company or any Subsidiary which is located within the U.S. and the net book value of which on the date as of which the determination is being made exceeds 1%
of Consolidated Net Tangible Assets, other than any such manufacturing plant or warehouse or portion thereof (1)&nbsp;which is a pollution control or other facility financed by obligations issued by a state or local government unit and described in
Sections 141(a), 142(a)(5), 142(a)(6), 142(a)(10) or 144(a) of the Internal Revenue Code (or their successor provisions) or by any other obligations the interest of which is excluded under Section&nbsp;103 of the Internal Revenue Code (or its
successor provision), or (2)&nbsp;which, in the opinion of the Company&#146;s board of directors is not of material importance to the total business conducted by the Company and its Subsidiaries taken as a whole. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7. REPURCHASE AT OPTION OF HOLDER. Upon the occurrence of a Change of Control Triggering
Event, and subject to certain conditions set forth in the Indenture, the Company will be required to offer to purchase all of the Outstanding Notes at a purchase price equal to 101% of the principal amount thereof, plus accrued and unpaid interest,
if any, thereon to the date of repurchase. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8. CERTAIN COVENANTS. The Indenture restricts, among other things, the ability of the Company
to merge or consolidate with, or transfer all or substantially all of its assets to, other companies. These covenants, as well as the covenants set forth in this Note, are subject to the defeasance procedures outlined in the Indenture. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">9. EFFECT OF EVENT OF DEFAULT. If an Event of Default shall have occurred and be continuing under the Indenture, the principal hereof may be
declared immediately due and payable in the manner, with the effect and subject to the conditions provided in the Indenture. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">10.
DEFEASANCE. The Indenture contains provisions for legal defeasance and covenant defeasance at any time of the Indebtedness on this Note upon compliance by the Company with certain conditions set forth therein. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">11. DENOMINATIONS; EXCHANGES. (a)&nbsp;The Notes are issuable in registered form without coupons in a minimum denomination of $2,000 and
integral multiples of $1,000 in excess thereof at the office or agency of the Company in the Borough of Manhattan, The City of New York, and in the manner and subject to the limitations provided in the Indenture, Notes may be exchanged for a like
aggregate principal amount of Notes of other authorized denomination. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">12. HOLDER AS OWNER. Prior to the due presentment of this Note for
registration of transfer, the Company, the Trustee, any Registrar and any Paying Agent of the Company or the Trustee may deem and treat the registered holder hereof as the absolute owner of this Note (whether or not this Note shall be overdue and
notwithstanding any notation of ownership or other writing hereon), for the purpose of receiving payment of, or on account of, the principal hereof and, subject to the provisions on the face hereof, interest hereon, and for all other purposes, and
none of the Company, the Trustee, any Registrar or any Paying Agent of the Company or the Trustee shall be affected by any notice to the contrary. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">13. NO LIABILITY OF CERTAIN PERSONS. No recourse under or upon any obligation, covenant or agreement of the Company in the Indenture or any
indenture supplemental thereto or in any Note, or because of the creation of any Indebtedness represented thereby, shall be had against any past, present or future incorporator, shareholder, officer or director, as such, of the Company or of any
successor, either directly or through the Company, or any successor corporation, under any constitution, statute or rule of law or by the enforcement of any assessment or otherwise, all such liability being expressly waived and released by the
acceptance hereof and as part of the consideration for the issue hereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">14. GOVERNING LAW. This Note shall be governed by, and construed
in accordance with, the laws of the State of New York without regard to conflict of law provisions thereof. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ASSIGNMENT FORM </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">FOR VALUE RECEIVED, the undersigned hereby sell(s), assign(s) and transfer(s) unto: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>PLEASE INSERT SOCIAL SECURITY NUMBER OR TAXPAYER </I></B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>IDENTIFICATION NUMBER OF ASSIGNEE </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">________________________________ </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>PLEASE PRINT OR TYPE
NAME AND ADDRESS, INCLUDING ZIP CODE, OF ASSIGNEE </I></B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">________________________________ </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">the within Note of Eastman Chemical Company and all rights thereunder and hereby irrevocably constitutes and appoints such person attorney to transfer such
Note on the books of Eastman Chemical Company, with full power of substitution in the premises. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dated:
<U>&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195; </U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Signature</B>:<U>&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8194; </U> </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="11%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="88%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">NOTICE:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><B>THE SIGNATURE TO THIS ASSIGNMENT MUST CORRESPOND WITH THE NAME AS WRITTEN UPON THE FACE OF THE WITHIN INSTRUMENT IN EVERY PARTICULAR, WITHOUT ALTERATION OR ENLARGEMENT OR ANY CHANGE WHATSOEVER. THE SIGNATURE SHOULD BE MEDALLION
GUARANTEED BY A COMMERCIAL BANK OR TRUST COMPANY, A MEMBER ORGANIZATION OF THE NEW YORK STOCK EXCHANGE</B>.</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Signature&nbsp;Guarantee:</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><B>Tax&nbsp;Identification&nbsp;No.:</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B><U>&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;</U></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><B><U>&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;</U></B></TD></TR>
</TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SCHEDULE OF INCREASES OR DECREASES IN NOTE </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The initial principal amount of this Note is U.S.$ . The following increases or decreases in the principal amount of this Note have been made:
</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="23%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="19%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="20%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="16%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="16%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman"><B>Date</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Amount of decrease in</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>principal amount of</B></P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>this
Note</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Amount of increase in</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>principal amount of</B></P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>this
Note</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Principal amount of</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>this Note following</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>such
decrease or</B></P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>increase</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Signature of</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>authorized signatory</B></P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>of
Trustee</B></P></TD></TR></TABLE>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>4
<FILENAME>d681849dex51.htm
<DESCRIPTION>EX-5.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-5.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 5.1 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="right">


<IMG SRC="g681849page60a.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">+1 617 526 6000 (t) </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">+1 617 526 5000 (f) </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">wilmerhale.com
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">February&nbsp;20, 2024 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Eastman Chemical Company </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">200 South Wilcox Drive </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Kingsport, Tennessee 37662 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Re: <U>5.625% Notes due 2034</U> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Ladies and Gentlemen: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have acted as counsel for Eastman Chemical Company, a Delaware corporation (the &#147;<I>Company</I>&#148;), in connection with the offer
and sale by the Company<I> </I>of $750,000,000 aggregate principal amount of the Company&#146;s 5.625% Notes due 2034 (the &#147;<I>Notes</I>&#148;) pursuant to an underwriting agreement dated February&nbsp;15, 2024 (the &#147;<I>Underwriting
Agreement</I>&#148;) among the Company and BofA Securities, Inc., Citigroup Global Markets Inc., J.P. Morgan Securities LLC, Mizuho Securities USA LLC and Wells Fargo Securities, LLC, as representatives of the several underwriters named in Schedule
1 to the Underwriting Agreement. The Notes will be issued pursuant to an Indenture dated as of June&nbsp;5, 2012 (the &#147;<I>Indenture</I>&#148;) between the Company and Computershare Trust Company, National Association (as successor to Wells
Fargo Bank, National Association), as trustee (the &#147;<I>Trustee</I>&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As such counsel, we have assisted in the preparation and
filing with the Securities and Exchange Commission (the &#147;<I>Commission</I>&#148;) of the Registration Statement on Form <FONT STYLE="white-space:nowrap">S-3</FONT> (File <FONT STYLE="white-space:nowrap">No.&nbsp;333-257008)</FONT> under the
Securities Act of 1933, as amended (the &#147;<I>Securities Act</I>&#148;), on June&nbsp;11, 2021 (the &#147;<I>Registration Statement</I>&#148;), including the prospectus dated June&nbsp;11, 2021 (the &#147;<I>Base Prospectus</I>&#148;), as
supplemented by the preliminary prospectus supplement dated February 15, 2024 (the &#147;<I>Preliminary Prospectus Supplement</I>&#148;), and the prospectus supplement dated February&nbsp;15, 2024 (the &#147;<I>Prospectus Supplement</I>&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have examined and relied upon corporate or other proceedings of the Company regarding the authorization, execution and delivery of the
Indenture, the Underwriting Agreement and the issuance of the Notes, the Registration Statement, the Base Prospectus, the Preliminary Prospectus Supplement and the Prospectus Supplement. We have also examined and relied upon originals or copies,
certified or otherwise identified to our satisfaction, of such other corporate records of the Company, such other agreements and instruments, certificates of public officials, officers of the Company and other persons, and such other documents,
instruments and certificates as we have deemed necessary as a basis for the opinions hereinafter expressed. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g681849page60aa.jpg" ALT="LOGO">
 </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="right">


<IMG SRC="g681849page60a.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Eastman Chemical Company </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">February 20, 2024 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"> Page
 2
 </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In our examination of the documents referred to above, we have assumed the genuineness of all
signatures, the legal capacity of all signatories, the authenticity and completeness of all documents submitted to us as originals, the conformity to original documents of all documents submitted to us as copies, the authenticity of such original
documents, and the completeness and accuracy of the corporate minute books of the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We are expressing no opinion herein as to the
application of any federal or state law or regulation to the power, authority or competence of any party to any agreement with respect to any of the Notes other than the Company. We have assumed that such agreements are the valid and binding
obligations of each party thereto other than the Company, and enforceable against each such other party in accordance with their respective terms. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In rendering the opinions set forth below, we have relied as to certain matters on information obtained from public officials and officers of
the Company, and we have assumed (i)&nbsp;the due execution and delivery, pursuant to due authorization, of the Indenture by the Trustee; (ii)&nbsp;that the Trustee has the power, corporate or other, to enter into and perform its obligations under
the Indenture; (iii)&nbsp;that the Indenture will be a valid and binding obligation of the Trustee; and (iv)&nbsp;that the Trustee has been qualified under the Trust Indenture Act of 1939, as amended. We have also assumed the due authentication of
the Notes by the Trustee. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have assumed for purposes of our opinions below that no authorization, approval or other action by, and no
notice to or filing with, any governmental authority or regulatory body or any other third party is required for the due execution, delivery or performance by the Company of the Indenture or the Notes or, if any such authorization, approval,
consent, action, notice or filing is required, it will have been duly obtained, taken, given or made and will be in full force and effect. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our opinion below is qualified to the extent that it may be subject to or affected by (i)&nbsp;applicable bankruptcy, insolvency,
reorganization, moratorium, usury, fraudulent conveyance or similar laws relating to or affecting the rights or remedies of creditors generally, (ii)&nbsp;duties and standards imposed on creditors and parties to contracts, including, without
limitation, requirements of materiality, good faith, reasonableness and fair dealing, (iii)&nbsp;general equitable principles, and (iv)&nbsp;acceleration of the Notes which may affect the collectability of that portion of the stated principal amount
thereof that might be determined to constitute unearned interest thereon. Furthermore, we express no opinion as to the availability of any equitable or specific remedy upon any breach of the Indenture or the Notes, or to the successful assertion of
any equitable defenses, inasmuch as the availability of such remedies or the success of any equitable defenses may be subject to the discretion of a court. We also express no opinion herein as to the laws of any state or jurisdiction other than the
state laws of the State of New York and the General Corporation Law of the State of Delaware. We also express no opinion herein with respect to compliance by the Company with securities or &#147;blue sky&#148; laws of any state or other jurisdiction
of the United States or of any foreign jurisdiction. We express no opinion and make no statement herein with respect to the antifraud laws of any jurisdiction. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="right">


<IMG SRC="g681849page60a.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Eastman Chemical Company </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">February 20, 2024 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"> Page
 3
 </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We also express no opinion herein as to any provision of any agreement (i)&nbsp;that may be
deemed to or construed to waive any right of the Company; (ii)&nbsp;to the effect that rights and remedies are not exclusive, that every right or remedy is cumulative and may be exercised in addition to or with any other right or remedy and does not
preclude recourse to one or more other rights or remedies; (iii)&nbsp;relating to the effect of invalidity or unenforceability of any provision of any agreement on the validity or enforceability of any other provision thereof; (iv)&nbsp;that is in
violation of public policy; (v)&nbsp;relating to indemnification and contribution with respect to securities law matters; (vi)&nbsp;that provides that the terms of any agreement may not be waived or modified except in writing; (vii)&nbsp;purporting
to indemnify any person against his, her or its own negligence or intentional misconduct; (viii)&nbsp;requiring the payment of penalties, consequential damages or liquidated damages or (ix)&nbsp;relating to choice of law or consent to jurisdiction.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On the basis of, and subject to, the foregoing, we are of the opinion that when the Notes have been duly executed by the Company and have
been duly authenticated by the Trustee in accordance with the terms of the Indenture and delivered to the purchasers thereof against payment of the consideration therefor duly approved by the Company, the Notes will constitute valid and binding
obligations of the Company, enforceable against the Company in accordance with their terms. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Please note that we are opining only as to
the matters expressly set forth herein, and no opinion should be inferred as to any other matters. This opinion is based upon currently existing statutes, rules, regulations and judicial decisions, and we disclaim any obligation to advise you of any
change in any of these sources of law or subsequent legal or factual developments that might affect any matters or opinions set forth herein. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We hereby consent to the filing of this opinion with the Commission as an exhibit to the Company&#146;s Current Report on Form <FONT
STYLE="white-space:nowrap">8-K</FONT> to be filed on the date hereof, which Form <FONT STYLE="white-space:nowrap">8-K</FONT> will be incorporated by reference into the Registration Statement in accordance with the requirements of Item 601(b)(5) of
Regulation <FONT STYLE="white-space:nowrap">S-K</FONT> under the Securities Act and to the use of our name therein and in the related Base Prospectus and in any prospectus supplement under the caption &#147;Legal Matters.&#148; In giving such
consent, we do not hereby admit that we are in the category of persons whose consent is required under Section&nbsp;7 of the Securities Act or the rules and regulations of the Commission. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="right">


<IMG SRC="g681849page60a.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Eastman Chemical Company </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">February 20, 2024 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"> Page
 4
 </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Very truly yours, </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U><I>/s/ </I>WILMER CUTLER PICKERING HALE AND DORR&#8195;&#8195;&#8195;&#8195;&#8195;&#8195; </U></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">WILMER CUTLER PICKERING HALE AND DORR LLP </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>5
<FILENAME>emn-20240220.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20231012.2 -->
<!-- Creation date: 2/21/2024 2:15:09 AM Eastern Time -->
<!-- Copyright (c) 2024 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema
  xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric"
  xmlns:num="http://www.xbrl.org/dtr/type/numeric"
  xmlns:us-types="http://fasb.org/us-types/2023"
  xmlns:emn="http://www.eastman.com/20240220"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:xbrli="http://www.xbrl.org/2003/instance"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
  xmlns:us-gaap="http://fasb.org/us-gaap/2023"
  attributeFormDefault="unqualified"
  elementFormDefault="qualified"
  targetNamespace="http://www.eastman.com/20240220"
  xmlns:xsd="http://www.w3.org/2001/XMLSchema">
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance" />
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd" namespace="http://xbrl.sec.gov/dei/2023" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/numeric" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/non-numeric" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/naics/2023/naics-2023.xsd" namespace="http://xbrl.sec.gov/naics/2023" />
    <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt" />
    <xsd:import schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd" namespace="http://fasb.org/us-gaap/2023" />
    <xsd:import schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd" namespace="http://fasb.org/us-types/2023" />
  <xsd:annotation>
    <xsd:appinfo>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="emn-20240220_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:title="Label Links, all" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="emn-20240220_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:title="Presentation Links, all" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="emn-20240220_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:title="Definition Links, all" xlink:type="simple" />
      <link:roleType roleURI="http://www.eastman.com//20240220/taxonomy/role/DocumentDocumentAndEntityInformation" id="Role_DocumentDocumentAndEntityInformation">
        <link:definition>100000 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
  <xsd:element id="emn_DocumentAndEntityInformationTable" name="DocumentAndEntityInformationTable" type="xbrli:stringItemType" substitutionGroup="xbrldt:hypercubeItem" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="emn_DocumentAndEntityInformationLineItems" name="DocumentAndEntityInformationLineItems" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>6
<FILENAME>emn-20240220_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20231012.2 -->
<!-- Creation date: 2/21/2024 2:15:11 AM Eastern Time -->
<!-- Copyright (c) 2024 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all" />
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" />
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" />
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" />
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" />
  <link:roleRef roleURI="http://www.eastman.com//20240220/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:href="emn-20240220.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://www.eastman.com//20240220/taxonomy/role/DocumentDocumentAndEntityInformation">
    <link:loc xlink:href="emn-20240220.xsd#emn_DocumentAndEntityInformationTable" xlink:type="locator" xlink:label="emn_DocumentAndEntityInformationTable" />
    <link:loc xlink:href="emn-20240220.xsd#emn_DocumentAndEntityInformationLineItems" xlink:type="locator" xlink:label="emn_DocumentAndEntityInformationLineItems" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis" xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain_2" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember" xlink:type="locator" xlink:label="us-gaap_CommonStockMember" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferrableNotesMember" xlink:type="locator" xlink:label="us-gaap_DeferrableNotesMember" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="emn_DocumentAndEntityInformationLineItems" xlink:to="emn_DocumentAndEntityInformationTable" order="1" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="emn_DocumentAndEntityInformationTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="1" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="23" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain_2" order="23.0001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonStockMember" order="24" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_DeferrableNotesMember" order="25" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="emn_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityRegistrantName" order="27.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="emn_DocumentAndEntityInformationLineItems" xlink:to="dei_AmendmentFlag" order="28.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="emn_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityCentralIndexKey" order="29.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="emn_DocumentAndEntityInformationLineItems" xlink:to="dei_DocumentType" order="34.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="emn_DocumentAndEntityInformationLineItems" xlink:to="dei_DocumentPeriodEndDate" order="35.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="emn_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityIncorporationStateCountryCode" order="36.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="emn_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityFileNumber" order="37.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="emn_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityTaxIdentificationNumber" order="38.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="emn_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityAddressAddressLine1" order="39.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="emn_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityAddressCityOrTown" order="40.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="emn_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityAddressStateOrProvince" order="41.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="emn_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityAddressPostalZipCode" order="42.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="emn_DocumentAndEntityInformationLineItems" xlink:to="dei_CityAreaCode" order="43.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="emn_DocumentAndEntityInformationLineItems" xlink:to="dei_LocalPhoneNumber" order="44.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="emn_DocumentAndEntityInformationLineItems" xlink:to="dei_WrittenCommunications" order="45.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="emn_DocumentAndEntityInformationLineItems" xlink:to="dei_SolicitingMaterial" order="46.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="emn_DocumentAndEntityInformationLineItems" xlink:to="dei_PreCommencementTenderOffer" order="47.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="emn_DocumentAndEntityInformationLineItems" xlink:to="dei_PreCommencementIssuerTenderOffer" order="48.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="emn_DocumentAndEntityInformationLineItems" xlink:to="dei_Security12bTitle" order="49.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="emn_DocumentAndEntityInformationLineItems" xlink:to="dei_TradingSymbol" order="50.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="emn_DocumentAndEntityInformationLineItems" xlink:to="dei_SecurityExchangeName" order="51.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="emn_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityEmergingGrowthCompany" order="52.001" priority="2" use="optional" />
  </link:definitionLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>7
<FILENAME>emn-20240220_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20231012.2 -->
<!-- Creation date: 2/21/2024 2:15:09 AM Eastern Time -->
<!-- Copyright (c) 2024 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
  xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cover [Abstract]</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Registrant Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amendment Flag</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Central Index Key</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Type</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Period End Date</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation State Country Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Incorporation State Country Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity File Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity File Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Tax Identification Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line One</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line One</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, City or Town</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, City or Town</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, State or Province</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, State or Province</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Postal Zip Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">City Area Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Local Phone Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Written Communications</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Written Communications</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Soliciting Material</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Soliciting Material</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Issuer Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Issuer Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security 12b Title</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security 12b Title</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Trading Symbol</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security Exchange Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Emerging Growth Company</link:label>
    <link:loc xlink:href="emn-20240220.xsd#emn_DocumentAndEntityInformationTable" xlink:type="locator" xlink:label="emn_DocumentAndEntityInformationTable" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="emn_DocumentAndEntityInformationTable" xlink:to="emn_DocumentAndEntityInformationTable_lbl" />
    <link:label xml:lang="en-US" xlink:label="emn_DocumentAndEntityInformationTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document And Entity Information [Table]</link:label>
    <link:label xml:lang="en-US" xlink:label="emn_DocumentAndEntityInformationTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document And Entity Information [Table]</link:label>
    <link:loc xlink:href="emn-20240220.xsd#emn_DocumentAndEntityInformationLineItems" xlink:type="locator" xlink:label="emn_DocumentAndEntityInformationLineItems" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="emn_DocumentAndEntityInformationLineItems" xlink:to="emn_DocumentAndEntityInformationLineItems_lbl" />
    <link:label xml:lang="en-US" xlink:label="emn_DocumentAndEntityInformationLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document And Entity Information [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:label="emn_DocumentAndEntityInformationLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document And Entity Information [Line Items]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis" xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_StatementClassOfStockAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Class of Stock [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Class of Stock [Axis]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_ClassOfStockDomain_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ClassOfStockDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Class of Stock [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_ClassOfStockDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Class of Stock [Domain]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember" xlink:type="locator" xlink:label="us-gaap_CommonStockMember" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockMember" xlink:to="us-gaap_CommonStockMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CommonStockMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock [Member]</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_CommonStockMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common Stock [Member]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferrableNotesMember" xlink:type="locator" xlink:label="us-gaap_DeferrableNotesMember" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferrableNotesMember" xlink:to="us-gaap_DeferrableNotesMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_DeferrableNotesMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Deferrable Notes [Member]</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_DeferrableNotesMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Deferrable Notes [Member]</link:label>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>8
<FILENAME>emn-20240220_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20231012.2 -->
<!-- Creation date: 2/21/2024 2:15:10 AM Eastern Time -->
<!-- Copyright (c) 2024 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
    xmlns:link="http://www.xbrl.org/2003/linkbase"
    xmlns:xlink="http://www.w3.org/1999/xlink"
    xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
    xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
    xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.eastman.com//20240220/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:href="emn-20240220.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.eastman.com//20240220/taxonomy/role/DocumentDocumentAndEntityInformation">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:loc xlink:href="emn-20240220.xsd#emn_DocumentAndEntityInformationTable" xlink:type="locator" xlink:label="emn_DocumentAndEntityInformationTable" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="emn_DocumentAndEntityInformationTable" order="21" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="emn-20240220.xsd#emn_DocumentAndEntityInformationLineItems" xlink:type="locator" xlink:label="emn_DocumentAndEntityInformationLineItems" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="emn_DocumentAndEntityInformationTable" xlink:to="emn_DocumentAndEntityInformationLineItems" order="22" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis" xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="emn_DocumentAndEntityInformationTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="23" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember" xlink:type="locator" xlink:label="us-gaap_CommonStockMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonStockMember" order="24" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferrableNotesMember" xlink:type="locator" xlink:label="us-gaap_DeferrableNotesMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_DeferrableNotesMember" order="25" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="emn_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityRegistrantName" order="27.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="emn_DocumentAndEntityInformationLineItems" xlink:to="dei_AmendmentFlag" order="28.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="emn_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityCentralIndexKey" order="29.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="emn_DocumentAndEntityInformationLineItems" xlink:to="dei_DocumentType" order="34.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="emn_DocumentAndEntityInformationLineItems" xlink:to="dei_DocumentPeriodEndDate" order="35.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="emn_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityIncorporationStateCountryCode" order="36.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="emn_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityFileNumber" order="37.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="emn_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityTaxIdentificationNumber" order="38.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="emn_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityAddressAddressLine1" order="39.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="emn_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityAddressCityOrTown" order="40.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="emn_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityAddressStateOrProvince" order="41.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="emn_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityAddressPostalZipCode" order="42.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="emn_DocumentAndEntityInformationLineItems" xlink:to="dei_CityAreaCode" order="43.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="emn_DocumentAndEntityInformationLineItems" xlink:to="dei_LocalPhoneNumber" order="44.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="emn_DocumentAndEntityInformationLineItems" xlink:to="dei_WrittenCommunications" order="45.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="emn_DocumentAndEntityInformationLineItems" xlink:to="dei_SolicitingMaterial" order="46.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="emn_DocumentAndEntityInformationLineItems" xlink:to="dei_PreCommencementTenderOffer" order="47.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="emn_DocumentAndEntityInformationLineItems" xlink:to="dei_PreCommencementIssuerTenderOffer" order="48.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="emn_DocumentAndEntityInformationLineItems" xlink:to="dei_Security12bTitle" order="49.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="emn_DocumentAndEntityInformationLineItems" xlink:to="dei_TradingSymbol" order="50.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="emn_DocumentAndEntityInformationLineItems" xlink:to="dei_SecurityExchangeName" order="51.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="emn_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityEmergingGrowthCompany" order="52.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>g681849page60a.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g681849page60a.jpg
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M 0$! 0$! 0        $" P0%!@<("0H+$  " 0,# @0#!04$!    7T! @,
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M=N)8XH==T^225@J*MRA+$] .>30 ^Z\3:#973VUUK-C!<1_?CDN%5E^H)XH
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MH]Q+ 7,4[7,@'S$L,KY?8GUH [FQBG@T^VANIO/N(XE627&-[ <M^)YH L4
@% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0!_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>g681849page60aa.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g681849page60aa.jpg
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M 0$! 0$! 0        $" P0%!@<("0H+$  " 0,# @0#!04$!    7T! @,
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M9FQ-O$?W3MWE=P7=TW;><4 )::S8WUP(+>;<[1^:F5($B9QN4G@C..GJ/44
M7Z "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * .&U+P_JT
M.JO<:9;PR16=P+ZT5V W/)\LL1]%^\^?5AZ4 :.I:9?0G3[>S6::!+:Y6<JX
M =V7@L">26S],]J ,E])UQ;%1%%>QR0V5BD2QW&T+(CGSN V/ND9]: ++6>M
MQ,\!COVT[[;* (IP91$R#8P+')4-NXSD9'&!0!JZ-87<6N:E/=F[,8\M;=II
MR59?+4,=H.W.X'G'KCK0 FEVMWH=_JRR6TES;WETUU%+%@D;E4%&!(Q@KP>F
M,=,4 9^I)KSWES)#:7BK/]BDC6.<8BVR_O5/S#'RXSC@^] #4TK45NHM]M<.
MR:V]P7>7<ODD/M(RW &X# _I0!$EAK<VC()UU-;\SVZW*_:%",%D!D="I!P5
MSZ<8&,B@#<\1V<SZ%!;6=O+<-'<VS!0X+;4E1B26//"GJ<F@"IJ&DWEI=VCZ
M*)5DEFGFN9&?*L[0LJ%QGD!MF !P!0!FW5AK%W8Z4]G975O?Q3[YFNI1(JL(
M)%+##G@LP&1ZYQQ0!<M(=3EU*T-Q:ZE;6HBB:-5N$?RG4GS%D))+9XYYR/0T
M 1Z5I^K6L>AO*MZ91=2O>^9<%QLV2!,@L1C)3@>F: ,LVNNZ9HIEEDOHG.G,
MLSM/YA\_S1L !;J5+#*\\COB@#I_#$R/%>QF6Z,R3EFBN%<&)6Y55W=1CO0!
MA2:#>R>!=2M_LMX+^22X*6_VC ;=*S+QNVXP1P?>@#1O%U:7Q"DL=G=BT'F*
MQ\U2KJT0Q\N> &!'0G/.<&@"MH6GZO VF6U]%>Q16]K;",PR($0HF)$<9[GT
MSD8QC% %_7TU1]3M/L5M=-%')#(TD4H"X$GSKMR/X>N<Y' &: ,R*P\0PW'G
M6WVE9W:^&9Y]\8!8F#*DD8Z=!QR* +OAZUO$UZ6\N+&ZMQ+I\$3M<2!R959]
MPX8_WAST- %FS^V67B#796TZ=XKAXG@==N),1A2.O'([XH PX=!US3-+-E&T
MCDVDK0?9I=JPW3RN_/(^4;E /3"GCF@"S?:;K,D&NR+]L-T\D*VQCN2JE=L6
M\J-V%^97ZX/)]: -G7+*<Z!';:>D[ND\! \TE]@E4MEF.3\H;J>>E &9>PZK
M,WB3R;.['VVU5+7]XHVN(W&1\WR\[?TH TM*CN=*>WLI!-<"Z+REV;BWP%PF
M"2<=><]?KP 9E]I6K+J^JSV?F)/=3VTEM<(^%5$ #HXSR/OG&#G?QS0 :;HE
M]!>Z5!)&5CTZ[NKAIBPQ(LADV =\_O.?3;]* +/B'3KF[OENM/@G@U2W1?LU
MW$X"."WS1R#/*\9Y'?(YH S+G3]9BTS4[>WM;YKFXNKDI(MU@!2&,3#+=.5'
M&,'KG% $L]GK:W&I74,%XSS1VK(!, 2@QYJ*"=H?&>W?K0!O00/'X?DB:WN+
MO<K_ +BZ92[J2?D/;&#@ ]L T <[_8FI6Z0V]O\ ;I-*AOH9(H7G(ECCVL'7
M=NR4!*X!.>#V H D:QUF*2XN#%?2(^HOYD:7&6-N0=A0%L !B"1P<?E0!/#I
M^JF^F@G?4BB1C[--YR;67RMI63'.[?DD@<G!!XH O>''N;/3]+TVXLKA'%F&
MEDEEWE9%V@J>3UR2.>QH R_$&D7FHZMK CLKEEGT^**WE2150S*TC#<">0"R
MYW @\]: )FM/$!OF+O(UP+N!XYHY,0^0%7S5*YZDB3M_$I[< %>VTW6"--^U
MI=2QP7^YV$Q21XS"P#.H?&0Y .#@XR!S0 QK'Q*;!US<"\^R727#++A99&_U
M1CY^7U!XP.#0!>T\ZEH\UZ\EK=3V[BU$:/-O.\_+(1DD\<''3@XH TO$.GC5
M;>WL)()'MYG9970@>6/+8!N3V8KC'<4 8D6G:T=0T*^U"V\Z]A>1)Y(F7"((
MF13S_>8[L#IN]J *OV;Q'):76VWO8I&DBFCBEFW*W[HAHV8.",M_$, '!QC-
M %Z2WUI+R^_T>YN+>:5=I$VQHP2P(^]AD'!!&T\X/0T +I,>KK)8+JMI>RA;
M6#:ZS >7*N?,\S##=DX.>01Q]0#+L-%UVTT5K6".Z@E?2)8\?:.%N=WR8^;Y
M3C/(XZ9H N74.OW/]HRPP7L>^6*2"*20;7 B(9#M?*@MW!X.#R,T .O=/UJ\
MMM;A87R79BG6V9)U$,BLO[L#G((X';G)S@T 23:;?-?74D*:A!'-I\,<#K+N
M,3AGWY4MR<,I]\'!S0!;O--U'4/!(M'B6._^1S'YA()20/MR23R%QR3C.,\4
M 1;=4LKC5M0M]/N)'U&XC$<:%-T2+&%,A#,!G(.!GTH =/I\HTWP[#9Z;-#%
M9W:,T+,I:.-59<M@X)Y!X)ZT 5WT.^-]+;B,F*36$U 3[A@1A5)7USE=N/0T
M 6M(T(6VK6TL(F2PT^VDM[59C\QWLI('?:H0 9YY/H,@'34 % !0 4 % !0
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MP"& (.0>E "T 5X[ZUE\ORYT;S':-0#U9<[A^&#^5 $LDJ1*&D8*"P4$^I.
M/S- #Z "@"FVJV*7AM&N%6<,$VD$#<1D#/3)!'% %DRHLJQ%@'8%@O<@8S_,
M?G0 ^@"M#J%I/&LD-PCHTAB!4Y!<$@CZ\&@"P"" 0<@]"* %H ;)(D43R2.$
M1 69F.  .I- $%I?VU\K-;R;MI 8%2I&1D<'F@"S0!5?4+6.\%HTA\\@':$)
MP#G&2!@=#U]* +5 !0 U'5QE>F2.F.AQ0 Z@ H * *T>H6<CVZ)<(S7*&2$
M_?48R1^8_.@":&:.XA2:%P\;C*L.A%  )4:5H@P,B ,5[@'./Y'\J %1UD17
M4Y5AD<8H 4D @$@9X'O0 M !0!@>(-+NK^Z@DMT9E6VGA;;.8L%S&1GU'R'-
M %-="U1;NY<S?.T;A9$<(N#&%5< 9 #<]<#&>Y% %F/3;B_;?.'-L9RQCD+*
M2HDFZJ>Q#)QW H H1V%Y;ZM:P/#+,Z21%9P9,1QJ#E<XP1QGD\Y]A0!V- %7
M4[=[O2KRVBQYDT+HN>F2I H YI]!U)U9MK!-T6^)IA(\@57!&6&-N64A?8GO
M0!=AT.Z2)6>3?./)&]Y"Q 5<'G'K[#- $MAHT]M=PW,C9F$G[QO,)RGE!<?]
M] ''XT ;M &?KEG+?Z+=6L&/-D7"Y;;W!Z]J ,-]#OCYSO;^='+(["![D[@Q
M50KE^^-IP.P/'2@ G\/WTQNTE19Q+!M9Y)/]8P"8QCD<J>#D#/'4T 23Z+?S
M2W 5?+:3S<S^<071AA$P.FWCGMMXZF@#;T^R^P_:8U 6%I=\2@Y"J57(]OFW
M'\: +M '.:]H]Y?7LLENI*RVOD#]\4 ;<3EA_$O/3ZCO0!)+IU]!-+<6Z+)+
M+))D>85X*@*>>P(Z>YH IMH>H>;.2I820!';S^6("<*<<?=/# C\S0 D>AZF
M+BR=VVK$%"B-P!%B0L>H/)4J#MXXQP* +-GH]Y;:I93%05BC5'8R9  4@A1P
M0<D<<@]>M '1T 4-:M9KW2+BWMPIE8#:&. 2"#U_"@#)O]*U&^EDNBBQ;VB5
MK='!,B)OZDC&<N#CI\O7F@!8?#T^Q#/(S2CRUWF8E@@7#C(QZGMS@'M0!3GT
M#6;B..2YN/,G(=6$<FT*?E5'!(.#A23@9!8XS0!T>G61LQ<,_,DTSN6SDD$G
M'Z=J +M &;=::]SK5M=F1TBB@D0['*DDLA'3J/E- &0VAWZ2Z>(E7$+J[N).
M=WF ODD$G*C Q@]B<4 *?#MXMK%';S^1+MC,D@<L2ZDY//L<9ZX^@H L+I=S
M;W'VV"V19282\2RG+!592-QZ]0>>N* (#H-S-92-=Q)/<'R2$\TD?*^Y@"?\
MGB@#IZ "@#FH].U!=,M[.6S62*WF9W03 "=26P/P)!P>.* %M]"O$2.5Y<72
M>4$D\PML SN'/7@X]\#- %2'0KV,HSV*/$J1K+!]H/[]E#@L3]6!YZ]3R!0!
M?LM$NH);>>:7S+F-X]TGF,<H(@K#GW_/KUH Z"@"GJ]M)>Z-?6L./-F@>--Q
MP,E2!0!D:E9:EJ#!_LH0^48XP9\>2^1B7CK_ #X]S0!9TO3[JTU>\FD7$,NX
M[F?<S$MD8QCC!Z'D= <"@"M)HNHM>/?"XC$SS/F,#'[MEV ;O8!6Z=10!5O-
M*ETZ*#$#W%KE-\"&1MSB-@6.T$]=ISW//7% #+70M3/E/*[[C;JNYI!\H\C8
M4.02?GYZ^_44 2C0M1^TW;.\C>8D@#),$W*P 5?NDC'OQQ[F@#;T6VGL]-6&
M=51@[%57LI)(SCC/TX]* -"@#F]:T*[O9-2N;1HUN);<10[FP&X<,K<=#N'X
M@'M0!"="U(WUS*LS!SN:.42  \#8A &< @=\<>Y% %[2]+O[:_,UU/OB*F7:
M')Q,^-XY_A&./]X^E $%]H4CZG/=Q0I+"[1LT&_;YGW@X]!G]V??9S0!&/#]
MZ]FZM/Y5RRQ+'('+F$+*6(&>N!M&>^T4 ;]C&\5C%'+&L;JN"JN6&?J>3Z\T
M 6* ,&YT.6:;5)R^YY9%EMXS(PCW+&H4L!Z,N?P% %&+0=16U*X 4.Q$1D +
M(3$2F5  SL?IZ^YH U;:TOK?1+B&';#<.7,"%LB$$\#/?'7'X#B@"E#X>N+=
MS;^;'+9L4?!&W!"%#Q[C;^1H CL=%O;=[,>0L9B\G;*)?]4BJ Z =PQ!_P"^
MN>@H ZB@""\B,]C/"L<<A>-E"2?=;(Z'':@#F+K2=9N+&2!580D_NXY9P\D9
MV$ [R#D;B.N2.HYZ &I:Z3-#J"7C-^],K&1MY.4,>-O_ 'T <?C0 MUI$T^H
MZA<K*Z>=;)%&$D*C<-_4#_>% &=<Z%?F\ MU6.)83&C++C@Q,,'C.=Y!X('?
MDT 2W.ASQN5@@$UIN)%OYQ3YBB@/GM@@G\<]: %FTC4#?6TJG+1NQ#M+N5 9
M"W0\YVD8P>>A&!0!#'HUXMM LMBLBQX$T7VD_OWVX\SVY_$YSU H Z*QBFM]
M/MH;B3S9HXU5WSG<P')H L4 <LV@:C'%=26[Q"YAF_T++' CRQ(/''$C#_@*
MT 1KX?OHYKI%CQ 8C$HCF"[@&39U!Y"J0=W&3C !H LVF@W"^5/*D:7$8A$9
M5S\BK*S$?]\-CCCJ.E "#0KQ(?.\W;>*% E#LQ4"+:<#_>YQWX/6@"AI^EW%
MT5E2Q:V$,D90.7&UO+96<!P.A8'WQZT 7;/0;AVB6Y@6.V4IYL/G%Q(P1PSG
MUR67KUQDT ;VGPRVVF6L$S;I8XD1SG.2  >>] %F@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
C@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@#_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139655300338448">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>Feb. 20, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_emn_DocumentAndEntityInformationLineItems', window );"><strong>Document And Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">EASTMAN CHEMICAL CO<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000915389<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Feb. 20,  2024<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation State Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">1-12626<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">62-1539359<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">200 South Wilcox Drive<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Kingsport<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">TN<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">37660<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(423)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">229-2000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre Commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre Commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember', window );">Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_emn_DocumentAndEntityInformationLineItems', window );"><strong>Document And Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Security 12b Title</a></td>
<td class="text">Common Stock, par value $0.01 per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">EMN<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_DeferrableNotesMember', window );">Deferrable Notes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_emn_DocumentAndEntityInformationLineItems', window );"><strong>Document And Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Security 12b Title</a></td>
<td class="text">1.875% Notes Due 2026<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">EMN26<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_emn_DocumentAndEntityInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">emn_DocumentAndEntityInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>emn_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_DeferrableNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_DeferrableNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>13
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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MP %#TG1X#SY['R73>RHY_U=3_ 102P,$%     @ 88)46)>*NQS     $P(
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MB^$_7G\!4$L! A0#%     @ 88)46 =!36*!    L0   !
M ( !     &1O8U!R;W!S+V%P<"YX;6Q02P$"% ,4    " !A@E18%*GC2^X
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M<W1Y;&5S+GAM;%!+ 0(4 Q0    ( &&"5%B7BKL<P    !,"   +
M      "  >8/  !?<F5L<R\N<F5L<U!+ 0(4 Q0    ( &&"5%@<.&7J/P$
M #P"   /              "  <\0  !X;"]W;W)K8F]O:RYX;6Q02P$"% ,4
M    " !A@E18)!Z;HJT   #X 0  &@              @ $[$@  >&PO7W)E
M;',O=V]R:V)O;VLN>&UL+G)E;'-02P$"% ,4    " !A@E1899!YDAD!  #/
M P  $P              @ $@$P  6T-O;G1E;G1?5'EP97-=+GAM;%!+!08
1    "0 ) #X"  !J%      !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.24.0.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>3</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>2</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="d681849d8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>100000 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.eastman.com//20240220/taxonomy/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" isOnlyDei="true" isUsgaap="true" original="d681849d8k.htm">d681849d8k.htm</File>
    <File>emn-20240220.xsd</File>
    <File>emn-20240220_def.xml</File>
    <File>emn-20240220_lab.xml</File>
    <File>emn-20240220_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="25">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>20
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "d681849d8k.htm": {
   "nsprefix": "emn",
   "nsuri": "http://www.eastman.com/20240220",
   "dts": {
    "inline": {
     "local": [
      "d681849d8k.htm"
     ]
    },
    "schema": {
     "local": [
      "emn-20240220.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd",
      "https://xbrl.sec.gov/country/2023/country-2023.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd",
      "https://xbrl.sec.gov/naics/2023/naics-2023.xsd"
     ]
    },
    "definitionLink": {
     "local": [
      "emn-20240220_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "emn-20240220_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "emn-20240220_pre.xml"
     ]
    }
   },
   "keyStandard": 22,
   "keyCustom": 0,
   "axisStandard": 1,
   "axisCustom": 0,
   "memberStandard": 2,
   "memberCustom": 0,
   "hidden": {
    "total": 3,
    "http://xbrl.sec.gov/dei/2023": 3
   },
   "contextCount": 3,
   "entityCount": 1,
   "segmentCount": 2,
   "elementCount": 29,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2023": 25
   },
   "report": {
    "R1": {
     "role": "http://www.eastman.com//20240220/taxonomy/role/DocumentDocumentAndEntityInformation",
     "longName": "100000 - Document - Document and Entity Information",
     "shortName": "Document and Entity Information",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "duration_2024-02-20_to_2024-02-20",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d681849d8k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "duration_2024-02-20_to_2024-02-20",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d681849d8k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://www.eastman.com//20240220/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CityAreaCode",
     "presentation": [
      "http://www.eastman.com//20240220/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "terseLabel": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfStockDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ClassOfStockDomain",
     "presentation": [
      "http://www.eastman.com//20240220/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Domain]",
        "terseLabel": "Class of Stock [Domain]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommonStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockMember",
     "presentation": [
      "http://www.eastman.com//20240220/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock [Member]",
        "terseLabel": "Common Stock [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferrableNotesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferrableNotesMember",
     "presentation": [
      "http://www.eastman.com//20240220/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferrable Notes [Member]",
        "terseLabel": "Deferrable Notes [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "emn_DocumentAndEntityInformationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.eastman.com/20240220",
     "localname": "DocumentAndEntityInformationLineItems",
     "presentation": [
      "http://www.eastman.com//20240220/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document And Entity Information [Line Items]",
        "terseLabel": "Document And Entity Information [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "emn_DocumentAndEntityInformationTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.eastman.com/20240220",
     "localname": "DocumentAndEntityInformationTable",
     "presentation": [
      "http://www.eastman.com//20240220/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document And Entity Information [Table]",
        "terseLabel": "Document And Entity Information [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://www.eastman.com//20240220/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentType",
     "presentation": [
      "http://www.eastman.com//20240220/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "terseLabel": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://www.eastman.com//20240220/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://www.eastman.com//20240220/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://www.eastman.com//20240220/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://www.eastman.com//20240220/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://www.eastman.com//20240220/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://www.eastman.com//20240220/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://www.eastman.com//20240220/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "terseLabel": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://www.eastman.com//20240220/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation State Country Code",
        "terseLabel": "Entity Incorporation State Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://www.eastman.com//20240220/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://www.eastman.com//20240220/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://www.eastman.com//20240220/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://www.eastman.com//20240220/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre Commencement Issuer Tender Offer",
        "terseLabel": "Pre Commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://www.eastman.com//20240220/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre Commencement Tender Offer",
        "terseLabel": "Pre Commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Security12bTitle",
     "presentation": [
      "http://www.eastman.com//20240220/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security 12b Title",
        "terseLabel": "Security 12b Title",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://www.eastman.com//20240220/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://www.eastman.com//20240220/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "us-gaap_StatementClassOfStockAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementClassOfStockAxis",
     "presentation": [
      "http://www.eastman.com//20240220/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Axis]",
        "terseLabel": "Class of Stock [Axis]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "TradingSymbol",
     "presentation": [
      "http://www.eastman.com//20240220/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://www.eastman.com//20240220/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "terseLabel": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Section": "14a",
   "Number": "240",
   "Subsection": "12"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>21
<FILENAME>0001193125-24-040003-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001193125-24-040003-xbrl.zip
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M=(IBPDIM<NQ-6EB;<?W9<UT6J,]0Y5S)"/'<CZ7?9-'?()Y_=P,@<'K%AI[
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M(V"?ZW$R\69)X>'*_0%Y:'"ATY*YZ#ZQ9$PZ#W7<5_\"G+T+/P]@FV$\"*=
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MSV<?Y>]D-_9W.I8[AL:"1%?6\.LBS,G'FL+C0$N:+(&^\SL[ZU+@A^\>#,!
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MYN8EG3P[YR0!D!%5@HJQI<PE'EAJBD[8;+ZKV)*RKN5%A$Z@Z[5P481(8TJ
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M/@;88KY'O"LP#J27\2H(5I(AON*F)CCT*,FPO.> M71FADH:V.N0(!8I!F-
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M]P;[R0(WHK *[% 5/5L<+Y[O%UH*/E1=\QYW(1XH*\C2%(<(1)RK2BG*\6!
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M#-_Y0M/?E4'T"@.XG53&1G*/@ZAGL&!!Y.99&;B>S99P)(^2-F*Q5L383:4
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MU=%O4C2' )0)7W<'ZL0."X,S7(X+4W83JU6*R40% $K?@'^8Y%:G*LHPY:_
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MG5VXK9HEU>,,U BE=ARP$8HHE &B2U7@M?&!3>U[5Q(Y*-:HJT6*Q(AXU!:
M?@66^=*3+[AR<N9D(-V"<%,_3R&G#I=1SG1)MX@6SHE9;::E]8A@TE&/2KB
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M81' R>WL/C6CR$*VMV_9N/C\^>H:%X_!_0S2)9H7%S2P-;+O&@I*'O\B'_&
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M9A0N$EY&E[),:+4TBP#L_TXI?^=F88O/ N:KGZ?405!.$ECJT+$_5+=4=U$
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MO#K=#[W 4MJ0FDX86MIN/L>\?DKT4#\]I_\V5EB--9QCN\PYWMS%L$*ST;"
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M\-F/?U",CX+-.)B:!YD(&3<L4'EB1 2]-+O/'[N,LQ,1\3G7 CIHL"'/I$H
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M=@;7&[O]+6PT8&MO)&#0%WN<JTWK7[N[NQL[>\^WMP_6BR'(]U&N=LM;YE%
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M8(%E+J,BT Y\;K>TH!)X:9D840LLE<==8$HYHN9$\QQ+TR #&.M.+&R1 @B
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M\]2N]2B9V6AT^0!6];?P=Y3PD'Y]^3]02P,$%     @ 8H)46/6P8_3B P
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M^\.,C7^C-C]E>?G!AK[X%U!+ P04    " !B@E18&I[U [('  #D50  %
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MS,_FQV.;(^:?^2F4;OD;4$L! A0#%     @ 8H)46$FR OTV&   BI    X
M             ( !     &0V.#$X-#ED.&LN:'1M4$L! A0#%     @ 8H)4
M6 6"?=Y<;@  SW0" !               ( !8A@  &0V.#$X-#ED97@Q,2YH
M=&U02P$"% ,4    " !B@E18M='78?0M  #^UP  $               @ 'L
MA@  9#8X,3@T.61E>#0R+FAT;5!+ 0(4 Q0    ( &*"5%@V 4+YNP\  (0Y
M   0              "  0ZU  !D-C@Q.#0Y9&5X-3$N:'1M4$L! A0#%
M  @ 8H)46/6P8_3B P  3 \  !               ( !]\0  &5M;BTR,#(T
M,#(R,"YX<V102P$"% ,4    " !B@E18=]Q^^KP%  #[,P  %
M    @ $'R0  96UN+3(P,C0P,C(P7V1E9BYX;6Q02P$"% ,4    " !B@E18
M&I[U [('  #D50  %               @ 'US@  96UN+3(P,C0P,C(P7VQA
M8BYX;6Q02P$"% ,4    " !B@E18-TR\#W(%  "#-P  %
M@ '9U@  96UN+3(P,C0P,C(P7W!R92YX;6Q02P4&      @ " #Z 0  ?=P
#

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>d681849d8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:us-gaap="http://fasb.org/us-gaap/2023"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="emn-20240220.xsd" xlink:type="simple"/>
    <context id="duration_2024-02-20_to_2024-02-20">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000915389</identifier>
        </entity>
        <period>
            <startDate>2024-02-20</startDate>
            <endDate>2024-02-20</endDate>
        </period>
    </context>
    <context id="duration_2024-02-20_to_2024-02-20_us-gaap-StatementClassOfStockAxis_us-gaap-CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000915389</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-02-20</startDate>
            <endDate>2024-02-20</endDate>
        </period>
    </context>
    <context id="duration_2024-02-20_to_2024-02-20_us-gaap-StatementClassOfStockAxis_us-gaap-DeferrableNotesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000915389</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:DeferrableNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-02-20</startDate>
            <endDate>2024-02-20</endDate>
        </period>
    </context>
    <dei:EntityRegistrantName
      contextRef="duration_2024-02-20_to_2024-02-20"
      id="Hidden_dei_EntityRegistrantName">EASTMAN CHEMICAL CO</dei:EntityRegistrantName>
    <dei:AmendmentFlag contextRef="duration_2024-02-20_to_2024-02-20" id="ixv-314">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey
      contextRef="duration_2024-02-20_to_2024-02-20"
      id="Hidden_dei_EntityCentralIndexKey">0000915389</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="duration_2024-02-20_to_2024-02-20" id="ixv-341">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="duration_2024-02-20_to_2024-02-20" id="ixv-342">2024-02-20</dei:DocumentPeriodEndDate>
    <dei:EntityIncorporationStateCountryCode contextRef="duration_2024-02-20_to_2024-02-20" id="ixv-343">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="duration_2024-02-20_to_2024-02-20" id="ixv-344">1-12626</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="duration_2024-02-20_to_2024-02-20" id="ixv-345">62-1539359</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="duration_2024-02-20_to_2024-02-20" id="ixv-346">200 South Wilcox Drive</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="duration_2024-02-20_to_2024-02-20" id="ixv-347">Kingsport</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="duration_2024-02-20_to_2024-02-20" id="ixv-348">TN</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="duration_2024-02-20_to_2024-02-20" id="ixv-349">37660</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="duration_2024-02-20_to_2024-02-20" id="ixv-350">(423)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="duration_2024-02-20_to_2024-02-20" id="ixv-351">229-2000</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="duration_2024-02-20_to_2024-02-20" id="ixv-352">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="duration_2024-02-20_to_2024-02-20" id="ixv-353">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="duration_2024-02-20_to_2024-02-20" id="ixv-354">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="duration_2024-02-20_to_2024-02-20" id="ixv-355">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle
      contextRef="duration_2024-02-20_to_2024-02-20_us-gaap-StatementClassOfStockAxis_us-gaap-CommonStockMember"
      id="ixv-356">Common Stock, par value $0.01 per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="duration_2024-02-20_to_2024-02-20_us-gaap-StatementClassOfStockAxis_us-gaap-CommonStockMember"
      id="ixv-357">EMN</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="duration_2024-02-20_to_2024-02-20_us-gaap-StatementClassOfStockAxis_us-gaap-CommonStockMember"
      id="ixv-358">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="duration_2024-02-20_to_2024-02-20_us-gaap-StatementClassOfStockAxis_us-gaap-DeferrableNotesMember"
      id="ixv-359">1.875% Notes Due 2026</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="duration_2024-02-20_to_2024-02-20_us-gaap-StatementClassOfStockAxis_us-gaap-DeferrableNotesMember"
      id="ixv-360">EMN26</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="duration_2024-02-20_to_2024-02-20_us-gaap-StatementClassOfStockAxis_us-gaap-DeferrableNotesMember"
      id="ixv-361">NYSE</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="duration_2024-02-20_to_2024-02-20" id="ixv-362">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
